Tissue cutting systems, devices and methods

Information

  • Patent Grant
  • 12102531
  • Patent Number
    12,102,531
  • Date Filed
    Monday, October 21, 2019
    5 years ago
  • Date Issued
    Tuesday, October 1, 2024
    3 months ago
Abstract
Methods, devices and systems for disabling and/or removing a mitral valve edge-to-edge repair device via minimally invasive, endovascular procedures. Additional procedures on a heart may sometimes become necessary after the installation of a mitral valve edge-to-edge repair device. To prepare for such additional procedures, the edge-to-edge repair device may be removed or disabled in minimally invasive ways (e.g., through an endovascular procedure), without requiring open access to the heart.
Description
BACKGROUND

The present invention relates generally to medical methods, devices, and systems. In particular, the present invention relates to methods, devices, and systems for the endovascular, percutaneous or minimally invasive surgical treatment of bodily tissues, such as tissue approximation or valve repair. More particularly, the present invention relates to cutting of leaflet tissue in preparation of subsequent implanting of a medical implant through minimally invasive procedures.


Surgical repair of bodily tissues often involves tissue approximation and fastening of such tissues in the approximated arrangement. When repairing valves, tissue approximation includes coapting the leaflets of the valves in a therapeutic arrangement which may then be maintained by fastening or fixing the leaflets. Such coaptation can be used to treat regurgitation which most commonly occurs in the mitral valve.


Mitral valve regurgitation is characterized by retrograde flow from the left ventricle of a heart through an incompetent mitral valve into the left atrium. During a normal cycle of heart contraction (systole), the mitral valve acts as a check valve to prevent flow of oxygenated blood back into the left atrium. In this way, the oxygenated blood is pumped into the aorta through the aortic valve. Regurgitation of the valve can significantly decrease the pumping efficiency of the heart, placing the patient at risk of severe, progressive heart failure.


Mitral valve regurgitation can result from many different mechanical defects in the mitral valve or the left ventricular wall. The valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, the papillary muscles themselves or the left ventricular wall may be damaged or otherwise dysfunctional. Commonly, the valve annulus may be damaged, dilated, or weakened, limiting the ability of the mitral valve to close adequately against the high pressures of the left ventricle.


One treatment for mitral valve regurgitation relies on valve replacement or repair including leaflet and annulus remodeling, the latter generally referred to as valve annuloplasty. One technique for mitral valve repair which relies on suturing adjacent segments of the opposed valve leaflets together is referred to as the “bow-tie” or “edge-to-edge” technique. While all these techniques can be effective, they usually rely on open heart surgery where the patient's chest is opened, typically via a sternotomy, and the patient placed on cardiopulmonary bypass. The need to both open the chest and place the patient on bypass is traumatic and has associated high mortality and morbidity.


In some patients, a fixation device can be installed into the heart using minimally invasive techniques. The fixation device can hold the adjacent segments of the opposed valve leaflets together and may reduce mitral valve regurgitation. One such device used to clip the anterior and posterior leaflets of the mitral valve together is the MitraClip® fixation device, sold by Abbott Vascular or Abbott Structural Heart, Santa Clara, Calif., USA.


However, sometimes after a fixation device is installed, undesirable mitral valve regurgitation can still exist, or can arise again. Further, other problems with the heart may arise that can make it desirable for the fixation device to be disabled or removed, usually in order that other procedures may be performed on the heart.


Current techniques for removing or disabling mitral valve fixation devices usually rely on open heart surgery where the patient's chest is opened, typically via a sternotomy, and the patient placed on cardiopulmonary bypass, which can pose a high risk of complications and extended patient recovery times.


For these reasons, it would be desirable to provide alternative and additional methods, devices, and systems for removing or disabling previously installed fixation devices. Such methods, devices, and systems should preferably not require open chest access and be capable of being performed either endovascularly, i.e., using devices which are advanced to the heart from a point in the patient's vasculature remote from the heart, or by another minimally invasive approach. The methods, devices, and systems may be useful for repair of tissues in the body other than heart valves. At least some of these objectives will be met by the inventions described hereinbelow.


BRIEF SUMMARY

The present disclosure describes methods, devices and systems that may be employed to detach a previously sutured “bowtie” or implanted device that clips together the anterior and posterior leaflets of a valve from one or all of the leaflets. The technology described and claimed herein could also be adapted to selectively target and cut tissue in other areas of the human anatomy via similar endovascular procedures.


These and other objects and features of the present disclosure will become more fully apparent from the following description and appended claims, or may be learned by the practice of the embodiments of the invention as set forth hereinafter.





BRIEF DESCRIPTION OF THE DRAWINGS

To further clarify the above and other advantages and features of the present disclosure, a more particular description of the invention will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. It is appreciated that these drawings depict only illustrated embodiments of the invention and are therefore not to be considered limiting of its scope. Embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:



FIG. 1 illustrates the left ventricle and left atrium of the heart during systole.



FIG. 2A illustrates free edges of leaflets of the mitral valve in normal coaptation, and FIG. 2B illustrates the free edges in regurgitative coaptation.



FIGS. 3A-3C illustrate grasping of the leaflets with a fixation device, inversion of the distal elements of the fixation device, and removal of the fixation device, respectively.



FIG. 4 illustrates the position of the fixation device in a desired orientation relative to the leaflets.



FIG. 5 illustrates a system for detaching an edge-to-edge repair device from one or more leaflets.



FIGS. 6A and 6B illustrate a cutting member according to one embodiment of the system of FIG. 5.



FIG. 7 illustrates a cutting member according to another embodiment of the system of FIG. 5.



FIG. 8 illustrates a cutting member according to another embodiment of the system of FIG. 5.



FIG. 9 illustrates a cutting member according to yet another embodiment of the system of FIG. 5.



FIG. 10 illustrates a catheter according to one embodiment of the system of FIG. 5.



FIGS. 11A-11C illustrate alternate cross-sectional views of the catheter of FIG. 10.



FIGS. 12A and 12B illustrate a catheter according to another embodiment of the system of FIG. 5.



FIG. 13A and 13B each illustrates a catheter according to other embodiments of the system of FIG. 5.



FIGS. 14A and 14B illustrate alternate cross-sectional views of the catheter of FIG. 13.



FIG. 15 illustrates another alternate cross-sectional view of yet another embodiment of a catheter of the system of FIG. 5.



FIG. 16 illustrates a partial cut-away view of a human heart, showing a distal portion of the leaflet cutting device inserted into the right atrium and into the septal wall.



FIG. 17 illustrates a partial cut-away view of a human heart, showing a distal portion of the leaflet cutting device after having passed through the septal wall into the left atrium of the heart and having been steered toward and positioned adjacent the mitral valve.



FIGS. 18A and 18B illustrate partial cut-away views of a human heart from the atrial side and from the ventricular side, respectively, showing distal portions of a cutting member and a capture member passing through orifices in the mitral valve from the left atrium into the left ventricle.



FIG. 19 illustrates a partial cut-away view of a human heart from the left ventricle, showing a shape-memory snare loop having been deployed from the capturing member in preparation for capturing the cutting member.



FIG. 20 illustrates a partial cut-away view of a human heart from the left ventricle, showing the cutting member having been advanced through the snare loop of the capturing member.



FIG. 21 illustrates a partial cut-away view of a human heart from the left ventricle, showing the snare loop being withdrawn back into the capturing member, thereby contacting and capturing the cutting wire.



FIGS. 22A-22C illustrate partial cut-away views of a human heart from the left ventricle, showing the snare being progressively withdrawn back into the capturing member so as to position an exposed portion of the cutting member in position preparatory for cutting a portion of the leaflet of the mitral valve adjacent the edge-to-edge repair device.



FIG. 23 illustrates a partial cut-away view of a human heart from the left atrium, showing the exposed portion of the cutting member cutting through a portion of one of the leaflets of the mitral valve around the edge-to-edge repair device.



FIG. 24 is a schematic view of the system of FIG. 5, showing one embodiment in which the capture member is withdrawn completely from the device, thereby drawing the cutting member distally through one lumen of the device, around the mitral valve and edge-to-edge repair device, and then back through another lumen of the device in a proximal direction, and thereby positioning an exposed cutting portion formed in the middle of the cutting member at the mitral valve.



FIG. 25 is a schematic representation of the system of FIG. 5, showing another embodiment in which the capture member is partially withdrawn in a proximal direction, thereby drawing a distal end portion of the cutting member around the mitral valve and edge-to-edge repair device, and thereby positioning an exposed cutting portion formed proximately the distal end of the cutting member.



FIGS. 26A-26D are schematic representations of yet another embodiment of the system of FIG. 5, in which a puncture is made in one of the leaflets of the mitral valve, the capturing member is inserted through the puncture, two separate cutting members are passed through the orifices located on opposite sides of the edge-to-edge repair device, which are then captured by the snare loop of the capturing member and then drawn proximally back into the capturing member so as to place exposed cutting portions of each cutting wire in position to cut portions of the leaflet around the edge-to-edge repair device.





DETAILED DESCRIPTION

As mentioned earlier, sometimes, after installation of an edge-to-edge repair device, such as a suture “bow-tie” or fixation device, in the heart, it needs to be removed or at least detached from one or both of anterior and posterior leaflets. Ordinarily, this has been done during a high-risk invasive procedure such as open-heart surgery. The presently described system 100, and associated devices and methods, however, allow a physician or clinician to address heart problems in a minimally invasive procedure.


For ease of explanation, FIG. 1 illustrates the left ventricle (LV) of a normal heart H in systole. The left ventricle (LV) is contracting and blood flows outwardly through the tricuspid (aortic) valve (AV) in the direction of the arrows. Back flow of blood or “regurgitation” through the mitral valve (MV) is prevented since the mitral valve is configured as a “check valve” which prevents back flow when pressure in the left ventricle is higher than that in the left atrium (LA). The mitral valve (MV) comprises a pair of leaflets having free edges (FE) which meet evenly to close, as illustrated in FIG. 1. The opposite ends of the leaflets (LF) are attached to the surrounding heart structure along an annular region referred to as the annulus (AN). The free edges (FE) of the leaflets (LF) are secured to the lower portions of the left ventricle LV through chordae tendinae (CT) (referred to hereinafter as the chordae) which include a plurality of branching tendons secured over the lower surfaces of each of the valve leaflets (LF). The chordae (CT) in turn, are attached to the papillary muscles (PM) which extend upwardly from the lower portions of the left ventricle and intraventricular septum IVS.


Several structural defects in the heart can cause mitral valve regurgitation. Regurgitation occurs when the valve leaflets do not close properly allowing leakage from the ventricle into the atrium. As shown in FIG. 2A, the free edges of the anterior and posterior leaflets normally meet along a line of coaptation (C). An example of a defect causing regurgitation is shown in FIG. 2B. Here an enlargement of the heart causes the mitral annulus to become enlarged, making it impossible for the free edges (FE) to meet during systole. This results in a gap (G) which allows blood to leak through the valve during ventricular systole. Ruptured or elongated chordae can also cause a valve leaflet to prolapse since inadequate tension is transmitted to the leaflet via the chordae. While the other leaflet maintains a normal profile, the two valve leaflets do not properly meet and leakage from the left ventricle into the left atrium will occur. Such regurgitation can also occur in patients who have suffered ischemic heart disease where the left ventricle does not contract sufficiently to effect proper closure.


Various fixation devices are used for grasping, approximating and fixating tissues, such as valve leaflets, to treat cardiac valve regurgitation, particularly mitral valve regurgitation. Certain fixation devices are described in in U.S. Pat. No. 7,563,267, which is incorporated herein by this reference. The fixation devices may rely upon the use of an interventional tool that is positioned near a desired treatment site and used to grasp the target tissue. In endovascular applications, the interventional tool is typically an interventional catheter. In surgical applications, the interventional tool is typically an interventional instrument. Fixation of the grasped tissue is accomplished by maintaining grasping with a portion of the interventional tool which is left behind as an implant. The fixation devices are well adapted for the repair of valves, especially cardiac valves such as the mitral valve.


Referring to FIG. 3A, an interventional tool 10, having a delivery device, such as a shaft 12, and a fixation device 14, is schematically illustrated having approached the mitral valve MV from the atrial side and grasped the leaflets LF. The mitral valve may be accessed either surgically or by using endovascular techniques, and either by a retrograde approach through the ventricle or by an antegrade approach through the atrium, as described above. For illustration purposes, an antegrade approach is described.


The fixation device 14 (sometimes also referred to herein as a “suture ‘bow-tie’” or an “edge-to-edge repair device”) is releasably attached to the shaft 12 of the interventional tool 10 at its distal end. When describing the devices of the invention herein, “proximal” shall mean the direction toward the end of the device to be manipulated by the user outside the patient's body, and “distal” shall mean the direction toward the working end of the device that is positioned at the treatment site and away from the user. With respect to the mitral valve, proximal shall refer to the atrial or upstream side of the valve leaflets and distal shall refer to the ventricular or downstream side of the valve leaflets.


The fixation device 14 typically comprises proximal elements 16 (or gripping elements) and distal elements 18 (or fixation elements) which protrude radially outward and are positionable on opposite sides of the leaflets LF as shown to capture or retain the leaflets therebetween. The proximal elements 16 are preferably comprised of cobalt chromium, nitinol or stainless steel, and the distal elements 18 are preferably comprised of cobalt chromium or stainless steel, however any suitable materials may be used. The fixation device 14 is coupleable to the shaft 12 by a coupling mechanism 17. The coupling mechanism 17 allows the fixation device 14 to detach and be left behind as an implant to hold the leaflets together in the coapted position.


In some situations, it may be desired to reposition or remove the fixation device 14 after the proximal elements 16, distal elements 18, or both have been deployed to capture the leaflets LF. Such repositioning or removal may be desired for a variety of reasons, such as to reapproach the valve in an attempt to achieve better valve function, more optimal positioning of the device 14 on the leaflets, better purchase on the leaflets, to detangle the device 14 from surrounding tissue such as chordae, to exchange the device 14 with one having a different design, or to abort the fixation procedure, to name a few. To facilitate repositioning or removal of the fixation device 14 the distal elements 18 may be released and optionally inverted to a configuration suitable for withdrawal of the device 14 from the valve without tangling or interfering with or damaging the chordae, leaflets or other tissue. According to another embodiment, any of the endovascular methods described herein for disabling or removal of the fixation device may also be used.



FIG. 3B illustrates inversion wherein the distal elements 18 are moveable in the direction of arrows 40 to an inverted position. Likewise, the proximal elements 16 may be raised, if desired. In the inverted position, the device 14 may be repositioned to a desired orientation wherein the distal elements may then be reverted to a grasping position against the leaflets as in FIG. 3A. Alternatively, the fixation device 14 may be withdrawn (indicated by arrow 42) from the leaflets as shown in FIG. 3C. Such inversion reduces trauma to the leaflets and minimizes any entanglement of the device with surrounding tissues. Once the device 14 has been withdrawn through the valve leaflets, the proximal and distal elements may be moved to a closed position or configuration suitable for removal from the body or for reinsertion through the mitral valve.



FIG. 4 illustrates the position of the fixation device 14 in a desired orientation in relation to the leaflets LF. This is a short-axis view of the mitral valve MV from the atrial side, therefore, the proximal elements 16 are shown in solid line and the distal elements 18 are shown in dashed line. The proximal and distal elements 16, 18 are positioned to be substantially perpendicular to the line of coaptation C. The device 14 may be moved roughly along the line of coaptation to the location of regurgitation. The leaflets LF are held in place so that during diastole, as shown in FIG. 4, the leaflets LF remain in position between the elements 16, 18 surrounded by openings or orifices 0 which result from the diastolic pressure gradient. Advantageously, leaflets LF are coapted such that their proximal or upstream surfaces are facing each other in a vertical orientation, parallel to the direction of blood flow through mitral valve MV. The upstream surfaces may be brought together to be in contact with one another or may be held slightly apart but will preferably be maintained in the vertical orientation in which the upstream surfaces face each other at the point of coaptation. This simulates the double orifice geometry of a standard surgical “bow-tie” repair where the edges of the leaflets are brought into apposition and sutured together to form the double orifice. Color Doppler echo will show if the regurgitation of the valve has been reduced. If the resulting mitral flow pattern is satisfactory, the leaflets may be fixed together in this orientation. If the resulting color Doppler image shows insufficient improvement in mitral regurgitation, the interventional tool 10 may be repositioned. This may be repeated until an optimal result is produced wherein the leaflets LF are held in place.


Once the leaflets are coapted in the desired arrangement, the fixation device 14 is then detached from the shaft 12 and left behind as an implant to hold the leaflets together in the coapted position.


Additional examples of interventional tools and systems and fixation devices are described in in U.S. Pat. No. 7,563,267, which is incorporated herein by this reference.


Sometimes, after construction of the suture “bow-tie” or installation of one or more fixation devices in the heart, it needs to be removed or at least detached from one or both of anterior and posterior leaflets. Ordinarily, this has been done during an invasive procedure such as open-heart surgery. Invasive procedures such as these often have high risk of complications. Further, sometimes mitral valve fixation devices, or the suture “bow-tie,” are installed on patients for whom open-heart or more invasive procedures are otherwise unnecessary or undesirable. For these patients, and even for patients in whom open-heart surgery is used, it would be beneficial to have devices and systems specifically designed for removing or at least detaching the suture “bow-tie” or fixation devices from one or both of anterior and posterior leaflets within an endovascular procedure, rather than a procedure requiring open heart access.


Minimally invasive systems, methods, and devices for removing or at least detaching the suture “bow-tie” or fixation devices from one or both of anterior and posterior leaflets are disclosed herein. These minimally invasive systems, methods, and devices allow a practitioner to remove or at least detaching the suture “bow-tie” or fixation devices from one or both of anterior and posterior leaflets and, optionally, then proceed to do perform other medical procedures in the heart, without necessarily requiring open heart access or other more invasive procedures. Such systems, methods, and devices are configured to be effective even if the suture “bow-tie” or fixation device has been installed for weeks, months, or years, such that tissue surrounding the device may have grown over, into, or around the suture “bow-tie” or fixation device.


An embodiment of the present invention discloses systems that can include guidewires, catheters and other components that can perform various specific functions, and also multifunctional catheters that can perform any combination of functions. Such functions may include holding or retaining an installed fixation device or the suture “bow-tie”; cutting a leaflet or leaflets; removing the suture “bow-tie” or a fixation device; and repairing the leaflet(s). Related methods for performing such functions are also disclosed.


The mitral valve may be accessed using the systems, methods, and devices disclosed and/or claimed herein either surgically or by using endovascular techniques, and either by a retrograde approach through the ventricle or by an antegrade approach through the atrium, as described above. For illustration purposes, an antegrade approach is described.


The devices and associated methods and systems described herein may be used in combination with imaging modalities such as x-ray, fluoroscopy, echocardiography, charge coupled device cameras, complementary metal oxide semiconductor cameras, magnetic resonance imaging, and other imaging modalities. The availability of such imaging modalities during such procedures may help practitioners visualize, for example, where the fixation devices are, how they are connected to the heart, and where to direct the various catheters and/or other devices.



FIG. 5 illustrates a system 100 that may be used to at least detach an edge-to-edge repair device, such as a suture “bow-tie” or a fixation device, from at least one of the anterior and posterior leaflets LF. The system 100 can achieve this without open access to the heart, via a minimally invasive intravascular procedure, and through a single transseptal puncture. It will be understood, however, that the system 100 can also be used to detach a suture “bow-tie” or a fixation device from both or all leaflets to which the fixation device is attached. Furthermore, the system 100 can be used with the suture “bow-tie” or fixation devices identified herein or various other devices that are used to repair the leaflets, such as during an edge-to-edge repair. The suture “bow-tie” or fixation devices can be considered as edge-to-edge repair devices.


As illustrated, the system 100 can take the form of an elongate member 102, such as a multicomponent catheter, which is adapted to be advanced through a patient's vasculature. Elongate member or catheter 102 can include a guiding catheter 110 through which a delivery catheter 120 can be advanced to a previously implanted edge-to-edge repair device (not shown). The guiding catheter 110 can be, in one configuration, a steerable catheter or introducer, such as a Steerable Introducer sold under the trademark AGILIS.


The guiding catheter 110 can be steered through the tortuous anatomy to the heart and, using a transseptal approach, advanced through the septum between the right and left atria toward the mitral valve (MV). Once in place, the guiding catheter 110, whether alone or in combination with the delivery catheter 120, can position a distal end 122 of the delivery catheter 120 relative to the mitral valve (MV) for performing edge-to-edge repair device detachment as described herein. The steerability of guiding catheter 110 can be achieved through any number of known structures and methods, including but not limited to those disclosed in U.S. Pat. No. 7,653,267. In some embodiments, delivery catheter 120 can also move axially relative to the guide catheter. In other embodiments, a distal end portion of delivery catheter 120 can also be steerable independent of, and in a different plane from, guiding catheter 110.


The delivery catheter 120 accommodates a capturing member 140 and a cutting member 150 that extends from a proximal end 124 to the distal end 122. The capturing member 140, such as a snare, is used to capture and aid with positioning a cutting region of the cutting member 150 relative to the tissue to be cut to detach the edge-to-edge repair device from the leaflets LF. As discussed in additional detail below, withdrawing the capturing member 140 into the delivery catheter 120, while at the same time advancing the cutting member 150, provides the desired looping and positioning of the cutting member 150 so that the cutting region of the cutting member 150 can be used to cut the leaflets.


To aid with such capturing, as illustrated in FIG. 5, the capturing member 140 can include a looped portion 144 at a distal end 142. This looped portion 144 can include a narrowed portion 146 that facilitates preferential collapsing of the capturing member 140 when the capturing member 140 draws the cutting member 150 into the distal end 122 of the delivery catheter 120. For instance, two halves of the looped portion 144 can collapse together with the narrowed portion 146 acting as a hinge or pivot that aids with the left and right sides moving together as the distal end 122 of the delivery catheter 120 contacts a proximal end 148 of the looped portion 144. It will be understood that other structures can be formed in the looped portion 144 to aid with the preferential collapsing. For instance, a wire forming the snare can be ground or narrowed to preferentially bend.


While FIG. 5 illustrates the capturing member 140 having the looped portion 144, other types of capturing mechanisms may include, but are not limited to, for example, sheaths, conduits, expandable baskets, vacuums, magnets, vices, and clamps. For instance, the capturing member 140 and the cutting member 150 can include magnets or be formed of materials that magnetically attract so that the distal end 152 of the cutting member 150 might be attracted to the distal end 142 of the capturing member 140 or vice versa.


The capturing member 140 can be a wire, tubular member, or other elongate structure and can be made of metal, plastic, shape-memory alloys or polymers, or any suitable material, e.g., such as those described herein (e.g., cobalt-chromium alloys, stainless steel, nickel-titanium, Elgiloy®, etc.


A distal end portion of capturing member 140 can include a pre-formed, resilient, shape-memory loop configuration and/or orientation, such as looped portion 144. The loop can collapse and straighten when held within the constraints of the delivery catheter 120. Once advanced distally beyond the distal end of the delivery catheter 120, the loop can self-expand and return to its pre-formed, shape-memory configuration and orientation.


Capturing member 140 can also include one or more radiopaque markers positioned adjacent and/or around the looped portion 144. As discussed in additional detail below, such radiopaque markers assist in locating and visualizing the location, position and orientation of such capturing member 140 and cutting member 150, as well as their respective locations, positions and orientations relative to one another.


The cutting member 150 can electrically communicate with an electrosurgical device 130 (such as an electrosurgical generator), which can selectively provide radio-frequency energy to the cutting member 150. The cutting member 150, therefore, can function as a probe electrode that can cut, coagulate, desiccate, and fulgurate tissue, such as the leaflets LF. More particularly, the cutting member 150 can be used to cut at least a portion of at least one of the anterior and posterior leaflets LF or other tissue to which the edge-to-edge repair device is coupled.


The cutting member 150 can include a conductive core 158 with an electrically insulating coating 160 formed over at least a portion of the core 158. In some configurations the cutting member 150 is a guide wire that includes a proximal end 154 that can be electrically connected or coupled to an electrosurgical device 130, which can be used to selectively apply electrical energy to cutting member 150. The electrical cooperation can occur through an uncoated or exposed portion 159 at the proximal end 154 of core 158, which can be connected to electrosurgical device 130. Additional details regarding the cutting member 140 will be provided in connection with FIGS. 6-9 below.


Portions of capturing member 140 and cutting member 150 can also include good torque characteristics. In other words, when rotational forces are applied at their respective proximal ends to cause rotational movement at the proximal ends, such rotational movement is translated relatively closely to the respective distal ends. In this manner, the relative positioning and orientation of the distal end of capturing member 140 (including any pre-formed bends or curves and/or loop 144) and the distal end of cutting member (including any pre-formed bends or curves) can be closely correlated to the rotational position of the corresponding proximal ends thereof.


System 100 can also include a handle or fixture, schematically illustrated at 112, located at or near the proximal end 124 of system 100. Handle or fixture 112 can incorporate any number of known structures and methods for manipulating and controlling the advancing, withdrawing, positioning and orienting of the various components of system 100, including, but not limited to, guiding member 110, delivery catheter 120, capturing member 140, cutting member 150 and other components and sub-components of system 100, relative to a patient's anatomy and/or relative one another.



FIGS. 6-9 illustrate various possible configurations of the cutting member 150. The cutting members illustrated in FIGS. 6 and 7 enable a full floss technique, wherein the capture member 140, such as a snare, pulls the distal end of cutting member 150 distally out the distal end of one lumen of the delivery catheter, around one of the leaflets of the mitral valve, and then pulls the distal end of the cutting member back through the other lumen of the delivery catheter in a proximal direction until the distal end of the cutting member exits the proximal end of the delivery catheter (as illustrated in FIG. 23). In contrast, the cutting members illustrated in FIGS. 8 and 9 can utilize and keep the capture member 140 in contact with the cutting member 150, only pulling a distal portion of the cutting member 150 around one leaf of the mitral valve and back into distal end of the delivery catheter 120 (as illustrated in FIG. 24). These latter embodiments will allow use of a cutting member having a shorter overall length, making it quicker and easier for the user to manipulate.


Each illustrated cutting member 150a-150d has a proximal end 154a-154d and a distal end 152a-152d. Formed at the distal end 152a-152d is an atraumatic tip 156a-156d that can be formed, in one configuration, from a coil. This atraumatic tip 156a-156d can be shaped by a physician or clinician using the cutting member 150 or can have a preformed shape to aid with positioning the cutting member 150 relative to the edge-to-edge repair device, leaflets, and the orifices O formed by the edge-to-edge repair device and the leaflets. The coil can be formed of a metal or alloy, or other deformable or resiliently deformable material.


Each cutting member 150a-150d has a conductive core 158a-158d and a coating 160a-160d disposed over the conductive core 158a-158d. The coating 160a-160d partially covers the conductive core 158a-158d, except for one or more bare regions 162a-162d where the conductive core 158a-158d is uncoated or exposed. These regions 162a-162d allow radio-frequency energy to be delivered from the conductive core 158a-158d or for such energy to be delivered to tissue contacting those regions 162a-162d to cut, coagulate, desiccate, and fulgurate the tissue. For instance, in FIGS. 6-9 each cutting member 150a-150d includes an uncoated, exposed contact region 159a-159d disposed at respective proximal ends 154a-154d that allow an electrical contact or coupling to be made with electrosurgical device 130. These regions 159a-159d accommodate electrical communication with the electrosurgical device 130. In FIG. 6, an uncoated, exposed cutting region 162a is disposed between the proximal end 154a and the distal end 152a of the cutting member 150a for tissue contact. In FIG. 7, two uncoated, exposed cutting regions 162b are included, one cutting region 162b located near the middle of cutting member 150b and a second cutting region 162b near the distal end 152b of cutting member 150b, again for tissue contact. In FIG. 8, an uncoated, exposed cutting region 162c is provided near the distal end 152c for tissue contact, without a second region disposed between the proximal end 154c and the distal end 152c.


In addition to the conductive core 158a-158d and the coating 160a-160d, each cutting member 150a-150d includes radiopaque markers 164a-164d. These markers 164a-164d define the peripheral bounds of the cutting regions 162a-162d and aid in positioning those regions of the cutting member 150a-150d. For instance, the markers 164a-164d can be viewed via fluoroscopy, x-ray, or other imaging technique. While the markers 164a-164d are illustrated defining the bounds of the cutting regions 162a-162d, other markers can be included to define other locations of the cutting member 150a-150d or any other part of the system 100 or relationship between two or more parts of the system 100.


Referring to FIG. 9, yet another embodiment of cutting member is illustrated, namely cutting member 150d. As with the other embodiments, cutting member 150d can include: an elongate electrically conductive core 158d; an electrically insulative coating 160d covering a large portion of the conductive core 158d; one or more bare, exposed cutting regions 162d; a bare, exposed contact region 159d; one or more radiopaque markers 164d positioned adjacent the cutting region 162d; and an atraumatic tip 156d. In addition, cutting member 150d can include one or more tapered transition regions, such as tapered transition region 165d located between a main body portion of the cutting member 150d and the cutting region 162d.


In one particular embodiment, the electrically conductive core 158d can be made of surgical quality steel and can have a diameter of approximately 0.014″ (or approximately 0.04 cm) at its proximal end and a diameter of approximately 0.005″ (or approximately 0.01 cm) to approximately 0.008″ (or approximately 0.02 cm) in the cutting region(s) 162d. Alternatively, a proximal portion of the cutting member could also be formed from a hypotube. Cutting member 150d can have an overall length of approximately 70″ (or approximately 180 cm), with a cutting region 162d of approximately 4″ (or approximately 10 cm) in length, and the atraumatic tip can be approximately 0.4″ (or approximately 1 cm) to approximately 1.2″ (or approximately 3 cm) in length.


The cutting member 150 can be a wire, tubular member, or other elongate structure, with the conductive core being made of a metal, alloy, conductive polymer, or other conductive material. The coating for the cutting member 150 can be a polymer, such as polyterafluoroethylene or other polymer, a hydrophilic coating, a composite material, or other material the can provide lubricity to the cutting member and/or insulative properties to limit unwanted electrical conductivity of the conductive core with the tissue or the other components of the system 100.


Turning to FIG. 10, illustrated is one configuration of the delivery catheter 120. Even though the delivery catheter 120 is depicted straight, one or more resilient, pre-formed bends or curved shapes could be formed at the distal end of delivery catheter 120 to aid in crossing and placing members 140 and 150. Such pre-formed bends or curves can be formed in the distal end portion during extrusion or other fabrication of delivery catheter 120. The delivery catheter 120 can be a microcatheter that is advanceable within a lumen of the guiding catheter 110. To accommodate the capturing member 140 and the cutting member 150, the delivery catheter 120 can have a multi-lumen structure, such as including a lumen 126 that can receive the capturing member 140 and a lumen 128 that can receive the cutting member 150. Alternatively, the delivery catheter can include additional lumens 126 and/or lumens 128, such as illustrated in FIG. 15 and discussed hereinafter.


The lumens 126 and 128 can extend from luer connectors 170 and 172, through extension tubular members 174 and 174, which can join the luer connectors 170 and 172 to a reminder of the delivery catheter 120, to the distal end 122. These lumens 126 and 128 can be formed during extrusion of the shaft 125 of the delivery catheter 120 when the shaft 125 is formed of a polymer or other material capable of being extruded. For instance, FIGS. 10a-10c illustrates different cross-sections for the shaft 125 and different lumen constructions.


As shown in FIG. 11A, the lumen 126a includes wings that generally surround or extend upwardly to overlap a portion of the lumen 128a in a transverse direction relative to a longitudinal axis of the lumen 128a. In FIG. 11B, the lumen 126b has a generally planar upper surface with a curved bottom surface that approximates the curvature of the shaft 125b. In FIG. 11C, both the lumen 128c and the lumen 126c include curvatures that approximate the curvature of the shaft 125c.


In addition to the shaft 125 and the lumens 126 and 128 having different cross-section, the distal end 122 of the shaft 125 can also have different configurations. For instance, as shown in FIGS. 12A and 12B, the tubular portions of the shaft 125 forming the lumen 126d and 128d can include a cut or slit 129 in the material so that the lumens 126d and 128d, and associated tubular portion, can be spaced apart. This provides for better manipulation of the delivery catheter 120d and better tension during the cutting process. The cross-section of the distal end 122d illustrated in FIG. 12B also aids with enhancing flexibility.


In addition to having the lumens 126 and 128 being formed from the material forming the shaft 125, such as when polymers are assembled to form the shaft 125, it is possible to include separate tubular members that are slidable relative to each other and/or relative to the shaft 125. This provides enhanced positioning capabilities for the delivery catheter 120 because each tubular member is independently advanceable and also independently positionable relative to the distal end 122 of the delivery catheter 120 and the mitral valve MV. Such a structure is illustrated in FIGS. 13, 14 and 15 and is further described below.


Illustrated in FIG. 13A is one configuration of the delivery catheter 120e. The delivery catheter 120e can be a microcatheter that is advanceable within a lumen of the guiding catheter 110. To accommodate capturing member 140 and cutting member 150, the delivery catheter 120e can also include a first tubular member 180 and a second tubular member 182. In this embodiment, lumens 126e and 128e of delivery catheter 120e can be configured and sized to receive first tubular member 182 and second tubular member 180, respectively. First tubular member 182 can extend through lumen 126e of delivery catheter 120e and terminate at its proximal end in a luer connector 170. The lumen formed within first tubular member 182 can be configured and sized to receive capturing member 140 therethrough. Similarly, second tubular member 180 can extend through lumen 128e of delivery catheter 120e and terminate at its proximal end in a luer connector 172. The lumen formed within tubular member 180 can be configured and sized to receive cutting member 150 therethrough.


The tubular members 180 and 182 can be moved forward and backward, or proximal and distal, relative to a shaft shell 186. Tubular members 180 and 182 can also move axially relative to, and independent of, one another. This allows for enhanced positioning of the distal ends of tubular members 180 and 182 (and, thus, enhanced positioning of capturing member 140 and cutting member 150) relative to the mitral valve MV during the procedure. For instance, the distal end of the tubular member 182 can be closer to the mitral valve MV than the distal end of the tubular member 180 during the procedure, or vice versa, to change the angle at which the looped portion 144 receives the distal end 152 of the cutting member 150. To further enhance the capabilities of the tubular members 180 and 182, one or both can be pre-formed with a resilient, pre-formed shape-memory curve or bend to aid with steerability and positioning of the distal ends of the tubular members 180 and 182 at desired locations within the heart. Thus, the positioning of the delivery catheter 120e and/or the distal ends of the various elements of capturing member 140 and cutting member 150 can be achieved by the steerability of the guiding catheter 110, pre-formed, shape-memory curves or bends in tubular members 180 and 182, or any combination thereof. In addition, a distal portion of the delivery catheter 120e could also be made to be independently steerable once it is advanced beyond the distal end of guiding catheter 110.



FIG. 13B illustrates yet another embodiment of the delivery catheter 120f that very similar to the embodiment shown in FIG. 13A, except that catheter 120f includes a side port 129f near the proximal end to receive cutting member 150 in a “monorail” or rapid-exchange fashion. This arrangement can simplify the insertion of cutting member 150 into the delivery catheter 120f and can also allow the overall length of cutting member to be shortened.


Alternatively, as illustrated in FIGS. 14A and 14B, delivery catheter 120a can be take the form of a simple outer shell 186 that surrounds tubular members 180 and 182 (without providing separate lumens, such as lumens 126e and 128e). The shell 186 can have a fixed shape, such as illustrated in FIG. 14A or can have a flexible form that approximates an outer surface profile of the tubular members 180 and 182, as shown in FIG. 13B. In FIG. 14B, while the shell 186 generally approximates the outer surface profile of the tubular members 180 and 182, spaces can be formed between the shell 186 and the tubular member 180 and 182, such as spaces 190. Varying a durometer of the polymer or material forming the shell 186 allows for the different configurations.


Generally, the shaft and other portions of the delivery catheters 120 can be fabricated from polymers, metals, alloys, combinations thereof, or other materials that can accommodate the manufacture of the delivery catheter.


Illustrated in FIG. 15 is another cross-sectional configuration of the delivery catheter described herein. As mentioned above, the delivery catheters 120 described herein can include multiple lumens, with those lumens accommodating or receiving either the capture member 140 and the cutting member(s) 150 directly or including tubular members, such as tubular members 180a, 180b and 182, that accommodate or receive the capture member 140 and the cutting members 150a and 150b.


The delivery catheter 120g of FIG. 15 can include 3 lumens: lumen 126g and two lumens 128g. Disposed within each of the lumens 128g is a tubular member 180a and 180b) (similar to the tubular member 180 described in reference to FIGS. 12 and 13), which can receive two separate cutting members 150a and 150b. Disposed within the lumen 126g is a needle 192, which can be used to puncture the septum and, optionally, leaflet tissue or tissue adjacent to the leaflets to allow passage of the capture member 140 through a leaflet or other tissue. Once used to puncture the leaflet or other tissue, the needle 192 can be removed and the capture member 140, whether alone or with the tubular member 182, can be advanced through the lumen 126g. This configuration allows the delivery device 120g to accommodate two cutting members 150a and 150b that can be used to cut tissue either sequentially or simultaneously.


The system 100 can be used to position the delivery catheter 120 in various spaces within a patient's anatomy. For instance, and as will be described herein, the system 100 can be used to position the capturing member 140 and the cutting member 150 relative to leaflets in apposition to an edge-to-edge repair device, such as the MitraClip® or a suture “bow-tie.” However, the presently described system 100 and associated methods and devices can be used for other valvular structures or other tissues in an anatomy.


The positioning and deployment of the leaflet cutting device is more particularly illustrated in FIGS. 16-23. In use, the guiding catheter 110 can access the left atrium LA from the femoral artery using the inferior vena cava as illustrated in FIG. 16. Following a trans septal puncture using an appropriately placed needle advanced through a lumen of the guiding catheter, the guiding catheter 110 is introduced into the left atrium as illustrated in FIG. 17. Once positioned in the left atrium, the steerability of guiding catheter 110 is used to direct the distal end of delivery catheter 120 toward and adjacent to the mitral valve as further shown in FIG. 17. In other words, the guiding catheter 110 can be steered toward the mitral valve (MV) so that the center of the guiding catheter 110 is substantially centered on the previously implanted edge-to-edge repair device. This can include generally aligning a longitudinal axis of the guiding catheter 110 toward the edge-to-edge repair device (not shown). Once in place, the delivery catheter 120 can be advanced along the lumen in preparation for deployment.


With an end of the guiding catheter 110 facing the edge-to-edge repair device, the distal ends of lumens 126 and 128 can be positioned through orifices 0 on either side of edge-to-edge repair device. For instance, where the embodiment shown in FIG. 12A is employed, the shaft of the delivery catheter 120 can be advanced so that the lumen 126d and the lumen 128d can each be advanced into a separate orifice located to either side of the edge-to-edge repair device, i.e., the lumen 126d extends through one orifice O and the lumen 128d extends through the other orifice O. Similarly, when the delivery catheter 120e or the delivery catheter 120f is deployed from the guiding catheter 120, the tubular members 180 and 182 are advanced into and through orifices O on either side of the edge-to-edge repair device so that the tubular member 180 is in one orifice O and the tubular member 182 is in the other orifice O as illustrated in FIGS. 18A and 18B.


With the delivery catheter 120 so positioned, the capture member 140 can be advanced from the lumen 128 (and from the tubular member 182) into the left ventricle. By so doing, the looped portion 144 can self-expand to form a ring or opening (as shown in FIG. 19) with which to receive the cutting member 150. As the cutting member 150 is advanced from the lumen 128 (and from the tubular member 180), it is captured by the looped portion 144 as shown in FIG. 20. The tubular members 180 and 182 can also be independently moved to help position the distal ends of the lumens 126 and 128. As mentioned above radiopaque markers can be provided at different locations around the looped portion 144, as well as at various locations on the distal end portion of the cutting member 150, to assist in locating and visualizing the relative locations, positions and orientation of such components relative to one another.


When the position of the cutting member 150 is verified through comparing the location of the radiopaque markers 164 against radiopaque markers formed on the proximal and distal ends of the looped portion 144, the capture member 140 can be withdrawn towards the deliver catheter 120, and the lumen 126 as illustrated in FIG. 22. Optionally, the cutting member 150 can also be advanced in a distal direction at the same time to form a loop in the cutting member 150 and/or vary a length of available cutting member to contact the leaflet that will be cut. The pushing of the cutting member 150 and pulling of the capture member 140 can position the cutting member 150, and more particularly, the bare cutting regions 162 in the desired leaflet location as shown in FIGS. 22A-22C.


Following positioning of the cutting member 150, the leaflet can be cut by applying electrical energy to the cutting member 150 and drawing the exposed cutting regions 162 through the leaflet tissue, as illustrated in FIG. 23, thereby detaching the edge-to-edge repair device from one of the leaflets while remaining attached to the other leaflet. Thereafter, the physician or clinician can then perform one or more of a mitral valve annuloplasty, balloon valvuloplasty, mitral valve repair, installation of a replacement valve, and combinations thereof.



FIG. 24 is a schematic view of the system of FIG. 13A, showing one embodiment (sometimes referred to herein as a “full floss” embodiment) in which the capture member 140 can be completely withdrawn from the device. In this embodiment, the capture member 140 is withdrawn in a proximal direction, thereby drawing the distal end of cutting member 150 distally through one lumen of the device (such as lumen 128), around the mitral valve and edge-to-edge repair device, and then back through the other lumen of the device (such as lumen 126) in a proximal direction, thereby positioning an exposed cutting region 162 formed in the middle of the cutting member 150 at the mitral valve. In addition, this allows for both uncoated ends 159 and 162 of the cutting member to be accessible at the proximal end of the device for connection to the electrosurgical device 130 and thereby form an electrical circuit for the passage of electrosurgical energy. In this embodiment, the capturing member 140 is completely withdrawn from the delivery catheter 120 in order to deploy and position the cutting member 150.



FIG. 25 is a schematic representation of the system of FIG. 13A, showing another embodiment in which the capture member 140 is only partially withdrawn in a proximal direction to position an exposed cutting portion 162 formed near a distal end portion of the cutting member 150 around the mitral valve and edge-to-edge repair device. With this embodiment, the overall of length of the capture member 140 can be shorter than that required with the embodiment of FIG. 24. However, this embodiment may require the use of a patient return electrode in order to complete the electrical circuit, since only one end of the cutting member is accessible at the proximal end of the device for connection to the electrosurgical device 130.


In an alternate approach, schematically illustrated in FIGS. 26A-26D, instead of capturing the distal end 152 of the cutting member 150 to position the cutting member 150, the cutting member 150 can be advanced through the leaflet as a puncturing tool without capturing or positioning with the capture member 140. For instance, a combination of puncturing and cutting the leaflet with the cutting member 150 and lassoing either with the capture member 140 or another lasso advanced through another lumen of the delivery catheter 120 can used to (i) puncture the leaflet, (ii) capture a portion of the edge-to-edge repair device, (iii) cut one leaflet, (iv) capture another portion of the edge-to-edge repair device, and (v) cut the other leaflet before removing the edge-to-edge repair device. This would allow for removal or at least partial detachment of multiple edge-to-edge repair devices from one or more leaflets.


This alternate approach, using the delivery catheter 120f, is schematically illustrated in FIGS. 26A-26D. With an end of the delivery catheter 120f facing the edge-to-edge repair device 18, the needle 192 can be advanced through the tissue of one of the leaflets, such as from a distal end of the tubular member 182, to create a puncture P through the tissue of one of the mitral valve leaflets and positioned adjacent the edge-to-edge repair device 18. Once the puncture is formed, the needle 192 is removed and the capture member 140 (and/or the lumen 126 containing capture member 140) is advance through the puncture P in the leaflet tissue and into the ventricle. Alternatively, the delivery catheter 120f can be advanced over the needle 192 and through the puncture to position a distal end of the delivery catheter 120f in a desired position to deploy the capture member 140. In still another configuration, the tubular member 182 is sized to accommodate the needle 192, and when the needle 192 is removed, receives the capture member 140. Telescoping the tubular member 182 over the needle 192, once it has punctured the tissue, can place the distal end of the lumen 126f in the ventricle so the capture member 140, once the needle 192 is removed and the capture member 140 is disposed within the lumen 126f, can be deployed from the lumen 126f into the desired location for capturing the cutting member 150, as shown in FIG. 26A.


With the capture member 140 in place, i.e., the looped portion 144 self-expands to form a ring or opening with which to receive the cutting members 150a and 150b, the two tubular members 180a and 180b are advanced to position the distal ends of tubular members 180a and 180b through orifices O on either side of the edge-to-edge repair device 18, as shown in FIG. 26B. The distal ends of the cutting members 150a and 150b are in position for deployment so they might be advance into the looped portion 144. The tubular members 180a, 180b and 182 can be moved together or independently to position the distal ends of the lumens 126f and 128f. Alternatively, any grouping of the tubular members 180a, 180b and 182 can be moved together. For example, the tubular members 180a and 180b can be moved together, while independently from the tubular member 182. Any combination of movement of the tubular members 180a, 180b and 182 is possible.


When the position of the cutting members 150a and 150b are verified through comparing the location of the radiopaque markers 164 against radiopaque markers formed on the proximal and distal ends of the looped portion 144, the capture member 140 can be withdrawn towards the deliver catheter 120, and the lumen 126, as shown in FIG. 26C. As capture member is withdrawn into tube 182, distal end portions of cutting members 150a and 150b are drawn through their respective orifices O, around the tissue separating each orifice and the puncture P and then pass into the distal end of lumen 126 of tube 182, as shown in FIG. 26D. Optionally, the cutting members 150a and/or 150b can be advanced to vary a length of available cutting member to contact the leaflet that will be cut. The pushing of the cutting members 150a and/or 150b and the pulling of the capture member 140 can position the cutting members 150a and 150b, and more particularly, the bare regions 162a and 162b in the desired leaflet location. In any event, once the exposed cutting regions of cutting members 150a and 150b are in the desired positions, the leaflet can then be cut by applying electrical energy to the cutting members 150a and 150b and drawing the exposed cutting regions 162 through the leaflet tissue located between each orifice O and puncture P. Alternatively, the tubular members 180a and 180b can optionally be moved to selectively isolate or insulate the tissue from the cutting member(s) 150. For instance, the tubular member 180a can be advanced to isolate or insulate the tissue, such as leaflet tissue, from the cutting member 150a, while the cutting member 150b is used to cut the tissue (i.e., the cutting member 150b is energized to cut the tissue). Thereafter, the tubular member 180a is retracted to expose the cutting member 150a and the tubular member 180b is advanced to isolate or insulate the tissue from the cutting member 150b, and then cutting member 150a can be energized to cut the tissue.


Once the edge-to-edge repair device 18 is successfully detached from a first one of the leaflets, then a physician or clinician can move onto performing other procedures. Alternatively, if it is desirable or necessary to completely remove the edge-to-edge repair device 18, delivery catheter 120f can also be used to sequentially cut the edge-to-edge repair device 18 from both leaflets of the mitral valve. In other words, delivery device 120f can first be deployed in the manner discussed above to cut one leaflet and then be subsequently deployed in a similar manner to cut the other leaflet. In either event, the physician or clinician can then move on to perform one or more of a mitral valve annuloplasty, balloon valvuloplasty, mitral valve repair, installation of a replacement valve, and combinations thereof.


The technology described and claimed herein could also be readily adapted to selectively target and cut tissue in other areas of the human anatomy via similar endovascular procedures.


In keeping with the foregoing embodiments and disclosure, the technology disclosed herein can be directed to systems, devices and methods for at least partially detaching an edge-to-edge repair device that holds together anterior and posterior leaflets of a mitral valve of a human heart. For example, the devices are directed to at least partially detaching an edge-to-edge repair device that holds together anterior and posterior leaflets of a mitral valve of a human heart and can include one or more of the following elements: an elongate member having a proximal end, a proximal end portion, a distal end portion and a distal end, the elongate member; a guiding catheter with a distal end portion that can be selectively bent to reorient the distal end portion of the elongate member; a delivery catheter coaxially located within the guiding catheter; a delivery catheter shell having a first lumen and a second lumen, each extending from a proximal end to a distal end of the delivery catheter shell; a first tubular member having a distal end portion and positioned within the first lumen and being moveable in an axial direction relative to the delivery catheter shell; a second tubular member having a distal end portion and positioned within the second lumen and being moveable in an axial direction relative to the delivery catheter shell; a capture member extending through the first tubular member and being movable in an axial direction relative to the first tubular member, the capture member having a self-expanding, shape-memory loop formed at a distal end thereof; and/or a first cutting member extending through the second tubular member and being movable in an axial direction relative to the second tubular member, the first cutting member comprising an electrically conductive core extending its entire length, an electrically insulative coating covering a major portion of the conductive core, and one or more uncoated, electrically conductive cutting regions. The devices can also include one or more of the following additional features: wherein one or both of the first and second tubular members include a preferential, shape-memory bend in the distal end portion thereof; wherein the cutting member comprises a first cutting region and a second cutting region, wherein the first cutting region is disposed at a proximal end of the cutting member and the second cutting region is disposed between the proximal end and a distal end of the cutting member; wherein the first cutting region is disposed at and forms a distal end of the cutting member, proximal of an atraumatic coil tip; wherein the cutting member further comprises one or more radiopaque markers defining peripheral bounds of the cutting regions; wherein the capture member comprises a self-expanding, shape-memory loop portion for capturing the cutting member; wherein the loop portion comprises a narrowed portion configured to facilitate preferential collapsing of the capture member upon drawing the capture member into the second tubular member; and/or wherein the capture member further comprises one or more radiopaque markers defining peripheral bounds of the loop portion.


Similarly, the methods can be directed to at least partially detaching an edge-to-edge repair device that holds anterior and posterior leaflets of the mitral valve together, wherein a first orifice in the mitral valve is located to one side of the edge-to-edge repair device and a second orifice in the mitral valve is located to an other side of the edge-to-edge repair device, and can include, for example, any one or more of the following steps or acts: advancing a capture member from a first catheter portion that extends from a distal end of a delivery catheter and through the first orifice; advancing a cutting member from a second catheter portion that extends from the distal end of the delivery catheter and through the second orifice; capturing the cutting member with the capture member and positioning the cutting member around a portion of one of the leaflets of the mitral valve adjacent to the edge-to-edge repair device; and/or cutting at least a portion of one of the leaflets adjacent to the edge-to-edge repair device to detach the edge-to-edge repair device from the at least one of the anterior or posterior leaflets.


In another embodiment, the methods can include any one or more of the following steps or acts: advancing an elongate member through a least a portion of the vasculature of a patient and into a left atrium of a patient's heart, the elongate member having a proximal end portion, distal end portion and a distal end, the proximal end portion being located and accessible outside the patient's vasculature, the elongate member having a guiding catheter with a distal end portion that can be selectively bent to reorient the distal end portion of the elongate member, the elongate member also having a delivery catheter coaxially located within the steering catheter, the delivery catheter having a first lumen and a second lumen, each extending from a proximal end to a distal end of the delivery catheter, the delivery catheter also having a capture member extending through the first lumen and cutting member extending through the second lumen; puncturing, with the distal end of the elongate member, a septal wall between the right atrium and a left atrium of the heart and advancing the distal end portion of the elongate member into the left atrium of the heart; bending the distal end portion of the steering catheter to direct the distal end portion of the elongate member toward the mitral valve and align the delivery catheter with the edge-to-edge repair device; advancing the capture member beyond the distal end of the delivery catheter and through the first orifice; advancing the cutting member beyond the distal end of the delivery catheter and through the second orifice; capturing a distal end portion of the cutting member with a distal end portion of the capture member; withdrawing the distal end portion of the capture member in a proximal direction through the first lumen to position a cutting region formed in the cutting member around a portion of one of the anterior or posterior leaflets of the mitral valve adjacent to the edge-to-edge repair device; and/or applying electrical energy to the cutting member to cause the cutting region to cut through a portion of the tissue of one of the anterior and posterior leaflets adjacent to the edge-to-edge repair device to detach the edge-to-edge repair device from the at least one of the anterior or posterior leaflets.


Further still, the methods can also include any one or more of the following additional steps or acts: advancing a distal end portion of the capture member beyond a distal end of the first catheter portion, the distal end portion of the capture member having a self-expanding, shape-memory loop, and allowing the self-expanding, shape-memory loop to deploy on a ventricular side of the mitral valve; advancing a distal end portion of the cutting member beyond a distal end of the second catheter portion and through the loop of the capturing member; withdrawing the capturing member in a proximal direction and causing the loop to snare the cutting member and draw it around the edge-to-edge repair device and into contact with a portion of the tissue of the leaflet between the first and second orifices and adjacent to the edge-to-edge repair device; withdrawing the capture member in a proximal direction until one of the electrically conductive cutting regions passes around and is positioned against the tissue of the leaflet adjacent the edge-to-edge repair device; advancing the cutting member in a distal direction to aid in positioning one of the electrically conductive cutting regions against the tissue of the leaflet adjacent the edge-to-edge repair device; applying electrical energy to the cutting member; positioning the first catheter portion in the first orifice and positioning the second catheter portion in the second orifice; positioning the first catheter portion in the first orifice by sliding the first catheter portion within a body of the delivery catheter; positioning the second catheter portion in the second orifice by sliding the second catheter portion within a body of the delivery catheter; positioning the first catheter portion independently of positioning a second catheter portion; positioning the first catheter portion relative to the second catheter portion by moving the first catheter portion away from the second catheter portion; positioning the first catheter portion relative to the second catheter portion, wherein the first catheter portion and the second catheter portion are formed at the distal end of the delivery catheter, the delivery catheter comprising a split portion that allows the first catheter portion to extend away from the second catheter portion; performing a procedure selected from the group consisting of mitral valve annuloplasty, balloon valvuloplasty, mitral valve repair, installation of a replacement valve, and combinations thereof; and/or withdrawing the snare into the second catheter portion while advancing the cutting member from the first catheter portion to vary a length of the cutting member exposed to the anterior and posterior leaflets.


The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims
  • 1. A method of at least partially detaching an edge-to-edge repair device that holds anterior and posterior leaflets of the mitral valve together, wherein a first orifice in the mitral valve is located to one side of the edge-to-edge repair device and a second orifice in the mitral valve is located to another side of the edge-to-edge repair device, the method comprising: advancing an elongate member through at least a portion of the vasculature of a patient and into a left atrium of a patient's heart, the elongate member having a proximal end portion, a distal end portion, and a distal end, the proximal end portion being located outside the patient's vasculature, the elongate member receiving a delivery catheter having a first catheter lumen and a second catheter lumen, each extending from a proximal end to a distal end of the delivery catheter, the delivery catheter also having a capture member extending through the first catheter lumen and a cutting member extending through the second catheter lumen;advancing a capture member from a-the first catheter lumen of the elongate member that extends from a distal end of a delivery catheter and through the first orifice;advancing a cutting member from a-the second catheter lumen of the elongate member that extends from the distal end of the delivery catheter and through the second orifice, wherein a distal end of the cutting member includes an atraumatic coil tip;capturing the cutting member with the capture member and positioning the cutting member around a portion of one of the leaflets of the mitral valve adjacent to the edge-to-edge repair device; andcutting at least a portion of one of the leaflets adjacent to the edge-to-edge repair device to detach the edge-to-edge repair device from the at least one of the anterior or posterior leaflets, wherein a distal end of the delivery catheter comprises a split portion that allows the first catheter lumen to extend away from the second catheter lumen.
  • 2. The method of claim 1, wherein the act of advancing the capture member further comprises advancing a distal end portion of the capture member beyond a distal end of the first catheter lumen, the distal end portion of the capture member having a self-expanding, shape-memory loop, and allowing the self-expanding, shape-memory loop to deploy on a ventricular side of the mitral valve.
  • 3. The method of claim 2, wherein the act of advancing the cutting member further comprises advancing a distal end portion of the cutting member beyond a distal end of the second catheter lumen and through the loop of the capturing member.
  • 4. The method of claim 3, wherein the step of capturing the cutting member further comprises withdrawing the capturing member in a proximal direction and causing the loop to snare the cutting member and draw it around the edge-to-edge repair device and into contact with a portion of the tissue of the leaflet between the first and second orifices and adjacent to the edge-to-edge repair device.
  • 5. The method of claim 4, wherein the cutting member includes one or more electrically conductive cutting regions positioned at one or more discrete locations along its length, and wherein the act of positioning the cutting member further comprises withdrawing the capture member in a proximal direction until one of the electrically conductive cutting regions passes around and is positioned against the tissue of the leaflet adjacent the edge-to-edge repair device.
  • 6. The method of claim 5, wherein the act of positioning the cutting member further comprises advancing the cutting member in a distal direction to aid in positioning one of the electrically conductive cutting regions against the tissue of the leaflet adjacent the edge-to-edge repair device.
  • 7. The method of claim 6, wherein the act of cutting at least a portion of one of the leaflets further comprises an act of applying electrical energy to the cutting member.
  • 8. The method of claim 1, further comprises positioning the first catheter lumen relative to the second catheter lumen by moving the first catheter lumen away from the second catheter lumen.
  • 9. The method of claim 1, further comprises positioning the first catheter lumen relative to the second catheter lumen, and wherein the first catheter lumen and the second catheter lumen are formed at the distal end of the delivery catheter.
  • 10. The method of claim 1, further comprising performing a procedure selected from the group consisting of mitral valve annuloplasty, balloon valvuloplasty, mitral valve repair, installation of a replacement valve, and combinations thereof.
  • 11. The method of claim 1, wherein capturing the cutting member with the capture member and positioning the cutting member in proximity with the edge-to-edge repair device comprises withdrawing a snare into the second catheter lumen while advancing the cutting member from the first catheter lumen to vary a length of the cutting member exposed to the anterior and posterior leaflets.
  • 12. A method of at least partially detaching an edge-to-edge repair device that holds anterior and posterior leaflets of the mitral valve together, wherein a first orifice in the mitral valve is located on one side of the edge-to-edge repair device and a second orifice in the mitral valve is located on another side of the edge-to-edge repair device, the method comprising: advancing an elongate member through at least a portion of the vasculature of a patient and into a left atrium of a patient's heart, the elongate member having a proximal end portion, a distal end portion, and a distal end, the proximal end portion being located and accessible outside the patient's vasculature, the elongate member having a guiding catheter with a distal end portion that can be selectively bent to reorient the distal end portion of the elongate member, the elongate member also having a delivery catheter coaxially located within the guiding catheter, the delivery catheter having a first lumen and a second lumen, each extending from a proximal end to a distal end of the delivery catheter, the delivery catheter also having a capture member extending through the first lumen and a cutting member extending through the second lumen;puncturing, with the distal end of the elongate member, a septal wall between the right atrium and a left atrium of the heart and advancing the distal end portion of the elongate member into the left atrium of the heart;bending the distal end portion of the guiding catheter to direct the distal end portion of the elongate member toward the mitral valve and align the delivery catheter with the edge-to-edge repair device;advancing the capture member beyond the distal end of the delivery catheter and through the first orifice;advancing the cutting member beyond the distal end of the delivery catheter and through the second orifice, wherein a distal end of the cutting member includes an atraumatic coil tip;capturing a distal end portion of the cutting member with a distal end portion of the capture member;withdrawing the distal end portion of the capture member in a proximal direction through the first lumen to position a cutting region formed in the cutting member around a portion of one of the anterior or posterior leaflets of the mitral valve adjacent to the edge-to-edge repair device; andapplying electrical energy to the cutting member to cause the cutting region to cut through a portion of the tissue of one of the anterior and posterior leaflets adjacent to the edge-to-edge repair device to detach the edge-to-edge repair device from the at least one of the anterior or posterior leaflets.
  • 13. A device for at least partially detaching an edge-to-edge repair device that holds together anterior and posterior leaflets of a mitral valve of a human heart, the device comprising: an elongate member having a proximal end, a proximal end portion, a distal end portion and a distal end, the elongate member comprising: a guiding catheter with a distal end portion that can be selectively bent to reorient the distal end portion of the elongate member;a delivery catheter coaxially located within the guiding catheter, the delivery catheter comprising: a delivery catheter shell having a first lumen and a second lumen, each extending from a proximal end to a distal end of the delivery catheter shell;a first tubular member having a distal end portion and positioned within the first lumen and being moveable in an axial direction relative to the delivery catheter shell; anda second tubular member having a distal end portion and positioned within the second lumen and being moveable in an axial direction relative to the delivery catheter shell;a capture member extending through the first tubular member and being movable in an axial direction relative to the first tubular member, the capture member having a self-expanding, shape-memory loop formed at a distal end thereof; anda first cutting member extending through the second tubular member and being movable in an axial direction relative to the second tubular member, the first cutting member comprising an electrically conductive core extending its entire length, an electrically insulative coating covering a major portion of the conductive core, one or more uncoated, electrically conductive cutting regions, and, a distal end that includes an atraumatic coil tip.
  • 14. The device of claim 13, wherein one or both of the first and second tubular members include a preferential, shape-memory or heat shape bend in the distal end portion thereof.
  • 15. The device of claim 13, wherein the first cutting member comprises a first cutting region and a second cutting region, wherein the first cutting region is disposed at a proximal end of the cutting member and the second cutting region is disposed between the proximal end and a distal end of the cutting member.
  • 16. The device of claim 15, wherein the first cutting region is disposed at and forms a distal end of the first cutting member, proximal of the atraumatic coil tip.
  • 17. The device of claim 13, wherein the first cutting member further comprises one or more radiopaque markers defining peripheral bounds of the cutting regions.
  • 18. The device of claim 13, wherein the capture member comprises a self-expanding, shape-memory loop portion for capturing the first cutting member.
  • 19. The device of claim 18, wherein the loop portion comprises a narrowed portion configured to facilitate preferential collapsing of the capture member upon drawing the capture member into the second tubular member.
  • 20. The device of claim 18, wherein the capture member further comprises one or more radiopaque markers defining peripheral bounds of the loop portion.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of priority based on U.S. Provisional Patent Application Ser. No. 62/748,947, filed Oct. 22, 2018 and entitled “Leaflet Cutting Devices and Methods.”

US Referenced Citations (558)
Number Name Date Kind
1996261 Storz Apr 1935 A
3296668 Aiken Jan 1967 A
3470875 Johnson et al. Oct 1969 A
3671979 Moulopoulos Jun 1972 A
3675639 Cimber Jul 1972 A
3776237 Hill et al. Dec 1973 A
3874388 King et al. Apr 1975 A
4007743 Blake Feb 1977 A
4056854 Boretos et al. Nov 1977 A
4091815 Larsen May 1978 A
4235238 Ogiu et al. Nov 1980 A
4312337 Donahue Jan 1982 A
4484579 Meno et al. Nov 1984 A
4487205 Di Giovanni et al. Dec 1984 A
4498476 Cerwin et al. Feb 1985 A
4510934 Batra Apr 1985 A
4531522 Bedi et al. Jul 1985 A
4578061 Lemelson Mar 1986 A
4641366 Yokoyama et al. Feb 1987 A
4686965 Bonnet et al. Aug 1987 A
4777951 Cribier et al. Oct 1988 A
4809695 Gwathmey et al. Mar 1989 A
4872455 Pinchuk et al. Oct 1989 A
4878495 Grayzel Nov 1989 A
4917089 Sideris Apr 1990 A
4944295 Gwathmey et al. Jul 1990 A
4969890 Sugita et al. Nov 1990 A
4994077 Dobben Feb 1991 A
5015249 Nakao et al. May 1991 A
5042707 Taheri Aug 1991 A
5047041 Samuels Sep 1991 A
5049153 Nakao et al. Sep 1991 A
5053043 Gottesman et al. Oct 1991 A
5071428 Chin Oct 1991 A
5069679 Taheri Dec 1991 A
5078722 Stevens Jan 1992 A
5078723 Dance et al. Jan 1992 A
5171259 Inoue Dec 1992 A
5190554 Coddington et al. Mar 1993 A
5217460 Knoepfler Jun 1993 A
5226911 Chee et al. Jul 1993 A
5254130 Poncet et al. Oct 1993 A
5282845 Bush et al. Feb 1994 A
5318525 West et al. Jun 1994 A
5320632 Heidmueller Jun 1994 A
5332402 Teitelbaum Jul 1994 A
5336227 Nakao et al. Aug 1994 A
5342393 Stack Aug 1994 A
5350399 Erlebacher et al. Sep 1994 A
5368601 Sauer et al. Nov 1994 A
5373854 Kolozsi Dec 1994 A
5387219 Rappe Feb 1995 A
5391182 Chin Feb 1995 A
5395030 Kuramoto et al. Mar 1995 A
5403326 Harrison et al. Apr 1995 A
5411552 Andersen et al. May 1995 A
5417684 Jackson et al. May 1995 A
5417699 Klein et al. May 1995 A
5417700 Egan May 1995 A
5423830 Schneebaum et al. Jun 1995 A
5423857 Rosenman et al. Jun 1995 A
5423882 Jackman et al. Jun 1995 A
5431666 Sauer et al. Jul 1995 A
5450860 O'Connor Sep 1995 A
5456400 Shichman et al. Oct 1995 A
5456684 Schmidt et al. Oct 1995 A
5472423 Gronauer Dec 1995 A
5478353 Yoon Dec 1995 A
5496332 Sierra et al. Mar 1996 A
5507755 Gresl et al. Apr 1996 A
5507757 Sauer et al. Apr 1996 A
5522873 Jackman et al. Jun 1996 A
5527322 Klein et al. Jun 1996 A
5536251 Evard et al. Jul 1996 A
5542949 Yoon Aug 1996 A
5554185 Block et al. Sep 1996 A
5562678 Booker Oct 1996 A
5569274 Rapacki et al. Oct 1996 A
5571085 Accisano, III Nov 1996 A
5571137 Marlow et al. Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5582611 Tsuruta et al. Dec 1996 A
5584803 Stevens et al. Dec 1996 A
5609598 Laufer et al. Mar 1997 A
5617854 Munsif Apr 1997 A
5618306 Roth et al. Apr 1997 A
5620461 Muijs Van De Moer et al. Apr 1997 A
5626588 Sauer et al. May 1997 A
5636634 Kordis et al. Jun 1997 A
5649937 Bito et al. Jul 1997 A
5662681 Nash et al. Sep 1997 A
5669917 Sauer et al. Sep 1997 A
5669919 Sanders et al. Sep 1997 A
5690671 McGurk et al. Nov 1997 A
5695504 Gifford, III et al. Dec 1997 A
5695505 Yoon Dec 1997 A
5706824 Whittier Jan 1998 A
5709707 Lock et al. Jan 1998 A
5716367 Koike et al. Feb 1998 A
5718725 Sterman et al. Feb 1998 A
5722421 Francese et al. Mar 1998 A
5725542 Yoon Mar 1998 A
5725556 Moser et al. Mar 1998 A
5741271 Nakao et al. Apr 1998 A
5741280 Fleenor Apr 1998 A
5746747 McKeating May 1998 A
5749828 Solomon et al. May 1998 A
5769812 Stevens et al. Jun 1998 A
5769863 Garrison Jun 1998 A
5782845 Shewchuk Jul 1998 A
5797927 Yoon Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5810849 Kontos Sep 1998 A
5810876 Kelleher Sep 1998 A
5820591 Thompson et al. Oct 1998 A
5820630 Lind Oct 1998 A
5823956 Roth et al. Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5836955 Buelna et al. Nov 1998 A
5840081 Andersen et al. Nov 1998 A
5843103 Wulfman Dec 1998 A
5853422 Huebsch et al. Dec 1998 A
5855590 Malecki et al. Jan 1999 A
5855614 Stevens et al. Jan 1999 A
5860990 Nobles et al. Jan 1999 A
5861003 Latson et al. Jan 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5895404 Ruiz Apr 1999 A
5895417 Pomeranz et al. Apr 1999 A
5906620 Nakao et al. May 1999 A
5908420 Parins Jun 1999 A
5947363 Bolduc et al. Sep 1999 A
5954732 Hart et al. Sep 1999 A
5957949 Leonhard et al. Sep 1999 A
5957973 Quiachon et al. Sep 1999 A
5972020 Carpentier et al. Oct 1999 A
5972030 Garrison et al. Oct 1999 A
5980455 Daniel et al. Nov 1999 A
5989284 Laufer Nov 1999 A
5997547 Nakao et al. Dec 1999 A
6007546 Snow et al. Dec 1999 A
6022360 Reimels et al. Feb 2000 A
6033419 Hamblin et al. Mar 2000 A
6053933 Balazs et al. Apr 2000 A
6056769 Epstein et al. May 2000 A
6063106 Gibson May 2000 A
6066146 Carroll et al. May 2000 A
6090118 McGuckin, Jr. Jul 2000 A
6099553 Hart et al. Aug 2000 A
6117144 Nobles et al. Sep 2000 A
6117159 Huebsch et al. Sep 2000 A
6123665 Kawano Sep 2000 A
6136010 Modesitt et al. Oct 2000 A
6139508 Simpson Oct 2000 A
6143024 Campbell et al. Nov 2000 A
6162233 Williamson, IV et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6165204 Levinson et al. Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6171320 Monassevitch Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6180059 Divino, Jr. et al. Jan 2001 B1
6197043 Davidson Mar 2001 B1
6203553 Robertson et al. Mar 2001 B1
6206893 Klein et al. Mar 2001 B1
6206907 Marino et al. Mar 2001 B1
6245079 Nobles et al. Jun 2001 B1
6264617 Bales et al. Jul 2001 B1
6267781 Tu Jul 2001 B1
6269819 Oz et al. Aug 2001 B1
6283127 Sterman et al. Sep 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6312447 Grimes Nov 2001 B1
6319250 Falwell et al. Nov 2001 B1
6332893 Mortier et al. Dec 2001 B1
6334860 Dorn Jan 2002 B1
6355030 Aldrich et al. Mar 2002 B1
6358277 Duran Mar 2002 B1
6368326 Dakin et al. Apr 2002 B1
6387104 Pugsley, Jr. et al. May 2002 B1
6402780 Williamson et al. Jun 2002 B2
6402781 Langberg et al. Jun 2002 B1
6406420 McCarthy et al. Jun 2002 B1
6419640 Taylor Jul 2002 B1
6419669 Frazier et al. Jul 2002 B1
6461366 Seguin Oct 2002 B1
6464707 Bjerken Oct 2002 B1
6482224 Michler et al. Nov 2002 B1
6485489 Teirstein et al. Nov 2002 B2
6494881 Bales et al. Dec 2002 B1
6508828 Akerfeldt et al. Jan 2003 B1
6517550 Konya et al. Feb 2003 B1
6533796 Sauer et al. Mar 2003 B1
6537314 Langberg et al. Mar 2003 B2
6540755 Ockuly et al. Apr 2003 B2
6551331 Nobles et al. Apr 2003 B2
6562037 Paton et al. May 2003 B2
6562052 Nobles et al. May 2003 B2
6575971 Hauck et al. Jun 2003 B2
6599311 Biggs et al. Jul 2003 B1
6616684 Vidlund et al. Sep 2003 B1
6619291 Hlavka et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6626921 Blatter et al. Sep 2003 B2
6626930 Allen et al. Sep 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6641592 Sauer et al. Nov 2003 B1
6656221 Taylor et al. Dec 2003 B2
6669687 Saadat Dec 2003 B1
6685648 Flaherty et al. Feb 2004 B2
6689164 Seguin Feb 2004 B1
6695866 Kuehn et al. Feb 2004 B1
6701929 Hussein Mar 2004 B2
6702825 Frazier et al. Mar 2004 B2
6702826 Liddicoat et al. Mar 2004 B2
6709382 Homer Mar 2004 B1
6709456 Langberg et al. Mar 2004 B2
6718985 Hlavka et al. Apr 2004 B2
6719767 Kimblad Apr 2004 B1
6740107 Loeb et al. May 2004 B2
6746471 Mortier et al. Jun 2004 B2
6752813 Goldfarb et al. Jun 2004 B2
6755777 Schweich et al. Jun 2004 B2
6764510 Vidlund et al. Jul 2004 B2
6767349 Ouchi Jul 2004 B2
6770083 Seguin Aug 2004 B2
6797002 Spence et al. Sep 2004 B2
6860179 Hopper et al. Mar 2005 B2
6875224 Grimes Apr 2005 B2
6926715 Hauck et al. Aug 2005 B1
6932810 Ryan Aug 2005 B2
6945978 Hyde Sep 2005 B1
6949122 Adams et al. Sep 2005 B2
6966914 Abe Nov 2005 B2
6986775 Morales et al. Jan 2006 B2
7004970 Cauthen III et al. Feb 2006 B2
7011669 Kimblad Mar 2006 B2
7033390 Johnson et al. Apr 2006 B2
7048754 Martin et al. May 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7112207 Allen et al. Sep 2006 B2
7226467 Lucatero et al. Jun 2007 B2
7258694 Choi et al. Aug 2007 B1
7288097 Seguin Oct 2007 B2
7291168 Macoviak et al. Nov 2007 B2
7338467 Lutter Mar 2008 B2
7381210 Zarbatany et al. Jun 2008 B2
7435257 Lashinski et al. Oct 2008 B2
7464712 Oz et al. Dec 2008 B2
7497822 Kugler et al. Mar 2009 B1
7533790 Knodel et al. May 2009 B1
7563267 Goldfarb et al. Jul 2009 B2
7563273 Goldfarb et al. Jul 2009 B2
7604646 Goldfarb et al. Oct 2009 B2
7608091 Goldfarb et al. Oct 2009 B2
7635329 Goldfarb et al. Dec 2009 B2
7655015 Goldfarb et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7955340 Michlitsch Jun 2011 B2
8216234 Long Jul 2012 B2
8257356 Bleich et al. Sep 2012 B2
8398708 Meiri et al. Mar 2013 B2
8435237 Bahney May 2013 B2
8496655 Epp et al. Jul 2013 B2
8500768 Cohen Aug 2013 B2
8523881 Cabiri et al. Sep 2013 B2
8623077 Cohn Jan 2014 B2
8690858 Machold et al. Apr 2014 B2
8821518 Saliman et al. Sep 2014 B2
8926588 Berthiaume et al. Jan 2015 B2
9126032 Khairkhahan et al. Sep 2015 B2
9211119 Hendricksen Dec 2015 B2
9370341 Ceniccola et al. Jun 2016 B2
9498331 Chang et al. Nov 2016 B2
9572666 Basude et al. Feb 2017 B2
9770256 Cohen et al. Sep 2017 B2
9949833 McCleary et al. Apr 2018 B2
10238493 Metchik et al. Mar 2019 B1
10667804 Basude et al. Jun 2020 B2
11013554 Coates May 2021 B2
11406250 Saadat Aug 2022 B2
20010002445 Vesely May 2001 A1
20010005787 Oz et al. Jun 2001 A1
20010010005 Kammerer et al. Jul 2001 A1
20010037084 Nardeo Nov 2001 A1
20010044568 Langberg et al. Nov 2001 A1
20010044635 Niizeki et al. Nov 2001 A1
20020013547 Paskar Jan 2002 A1
20020013571 Goldfarb et al. Jan 2002 A1
20020022848 Garrison et al. Feb 2002 A1
20020026233 Shaknovich Feb 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020035381 Bardy et al. Mar 2002 A1
20020042651 Liddicoat et al. Apr 2002 A1
20020055767 Forde et al. May 2002 A1
20020055774 Liddicoat May 2002 A1
20020055775 Carpentier et al. May 2002 A1
20020058910 Hermann et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020077687 Ahn Jun 2002 A1
20020087148 Brock et al. Jul 2002 A1
20020087169 Brock et al. Jul 2002 A1
20020103532 Langberg et al. Aug 2002 A1
20020147456 Diduch et al. Oct 2002 A1
20020156526 Hilavka et al. Oct 2002 A1
20020161378 Downing Oct 2002 A1
20020169360 Taylor et al. Nov 2002 A1
20020173811 Tu et al. Nov 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20020183766 Seguin Dec 2002 A1
20020183787 Wahr et al. Dec 2002 A1
20020183835 Taylor et al. Dec 2002 A1
20030005797 Hopper et al. Jan 2003 A1
20030045778 Ohline et al. Mar 2003 A1
20030050693 Quijano et al. Mar 2003 A1
20030069570 Witzel et al. Apr 2003 A1
20030069593 Tremulis et al. Apr 2003 A1
20030074012 Nguyen et al. Apr 2003 A1
20030083742 Spence et al. May 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030105520 Alferness et al. Jun 2003 A1
20030120340 Lisk et al. Jun 2003 A1
20030120341 Shennib et al. Jun 2003 A1
20030130669 Damarati Jul 2003 A1
20030130730 Cohn et al. Jul 2003 A1
20030144697 Mathis et al. Jul 2003 A1
20030167071 Martin et al. Sep 2003 A1
20030171776 Adams et al. Sep 2003 A1
20030187467 Schreck Oct 2003 A1
20030195562 Collier et al. Oct 2003 A1
20030208231 Williamson, IV et al. Nov 2003 A1
20030229395 Cox Dec 2003 A1
20030233038 Hassett Dec 2003 A1
20040002719 Oz et al. Jan 2004 A1
20040003819 St. Goar et al. Jan 2004 A1
20040015232 Shu et al. Jan 2004 A1
20040019377 Taylor et al. Jan 2004 A1
20040019378 Hlavka et al. Jan 2004 A1
20040024414 Downing Feb 2004 A1
20040030319 Korkor Feb 2004 A1
20040030382 St. Goar et al. Feb 2004 A1
20040034380 Woolfson et al. Feb 2004 A1
20040039442 St. Goar et al. Feb 2004 A1
20040044350 Martin Mar 2004 A1
20040044365 Bachman Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040049211 Tremulis et al. Mar 2004 A1
20040059345 Nakao et al. Mar 2004 A1
20040078053 Berg et al. Apr 2004 A1
20040087975 Lucatero et al. May 2004 A1
20040088047 Spence et al. May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040092962 Thornton et al. May 2004 A1
20040097979 Svanidze et al. May 2004 A1
20040106989 Wilson et al. Jun 2004 A1
20040111099 Nguyen et al. Jun 2004 A1
20040116848 Gardeski et al. Jun 2004 A1
20040116951 Rosengart Jun 2004 A1
20040122448 Levine Jun 2004 A1
20040127849 Kantor Jul 2004 A1
20040127981 Randert et al. Jul 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040127983 Mortier et al. Jul 2004 A1
20040133062 Pai et al. Jul 2004 A1
20040133063 McCarthy et al. Jul 2004 A1
20040133192 Houser et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133232 Rosenbluth et al. Jul 2004 A1
20040133240 Adams et al. Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040147826 Peterson Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040153144 Seguin Aug 2004 A1
20040162610 Laiska et al. Aug 2004 A1
20040167539 Kuehn et al. Aug 2004 A1
20040186486 Roue et al. Sep 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040220593 Greenhalgh Nov 2004 A1
20040220657 Nieminen et al. Nov 2004 A1
20040225233 Frankowski et al. Nov 2004 A1
20040225300 Goldfarb et al. Nov 2004 A1
20040225305 Ewers et al. Nov 2004 A1
20040225353 McGuckin et al. Nov 2004 A1
20040236354 Seguin Nov 2004 A1
20040242960 Orban Dec 2004 A1
20040243229 Vidlund et al. Dec 2004 A1
20040249452 Adams et al. Dec 2004 A1
20040249453 Cartledge et al. Dec 2004 A1
20040260393 Randert et al. Dec 2004 A1
20050004583 Oz et al. Jan 2005 A1
20050004665 Aklog Jan 2005 A1
20050004668 Aklog et al. Jan 2005 A1
20050021056 St. Goer et al. Jan 2005 A1
20050021057 St. Goer et al. Jan 2005 A1
20050033446 Deem et al. Feb 2005 A1
20050038383 Kelley et al. Feb 2005 A1
20050038508 Gabbay Feb 2005 A1
20050049698 Bolling et al. Mar 2005 A1
20050055089 Macoviak et al. Mar 2005 A1
20050059351 Cauwels et al. Mar 2005 A1
20050065453 Shabaz et al. Mar 2005 A1
20050085903 Lau Apr 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050149014 Hauck et al. Jul 2005 A1
20050159763 Mollenauer Jul 2005 A1
20050159810 Filsoufi Jul 2005 A1
20050192633 Montpetit Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050216039 Lederman Sep 2005 A1
20050228422 Machold et al. Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050251001 Hassett Nov 2005 A1
20050256452 DeMarchi et al. Nov 2005 A1
20050267493 Schreck et al. Dec 2005 A1
20050273160 Lashinski et al. Dec 2005 A1
20050277876 Hayden Dec 2005 A1
20060004247 Kute et al. Jan 2006 A1
20060009759 Chrisitian et al. Jan 2006 A1
20060015003 Moaddes et al. Jan 2006 A1
20060015179 Bulman-Fleming et al. Jan 2006 A1
20060020275 Goldfarb et al. Jan 2006 A1
20060020327 Lashinski et al. Jan 2006 A1
20060020334 Lashinski et al. Jan 2006 A1
20060030866 Schreck Feb 2006 A1
20060030867 Zadno Feb 2006 A1
20060030885 Hyde Feb 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060064115 Allen et al. Mar 2006 A1
20060064116 Allen et al. Mar 2006 A1
20060064118 Kimblad Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060089671 Goldfarb et al. Apr 2006 A1
20060089711 Dolan Apr 2006 A1
20060135961 Rosenman et al. Jun 2006 A1
20060135993 Seguin Jun 2006 A1
20060184198 Bales Aug 2006 A1
20060184203 Martin et al. Aug 2006 A1
20060195012 Mortier et al. Aug 2006 A1
20060229708 Powell Oct 2006 A1
20060252984 Randert et al. Nov 2006 A1
20060276890 Solem Dec 2006 A1
20070016225 Nakao Jan 2007 A1
20070038293 St. Goer et al. Feb 2007 A1
20070060997 de Boer Mar 2007 A1
20070073185 Nakao Mar 2007 A1
20070100356 Lucatero et al. May 2007 A1
20070118155 Goldfarb et al. May 2007 A1
20070129737 Goldfarb et al. Jun 2007 A1
20070173757 Levine et al. Jul 2007 A1
20070197858 Goldfarb et al. Aug 2007 A1
20070198082 Kapadia et al. Aug 2007 A1
20070260225 Sakakine et al. Nov 2007 A1
20070287884 Schena Dec 2007 A1
20080009858 Rizvi Jan 2008 A1
20080039935 Buch et al. Feb 2008 A1
20080045936 Vaska et al. Feb 2008 A1
20080051703 Thorton et al. Feb 2008 A1
20080051807 St. Goar et al. Feb 2008 A1
20080097467 Gruber et al. Apr 2008 A1
20080097489 Goldfarb et al. Apr 2008 A1
20080167714 St. Goer et al. Jul 2008 A1
20080183194 Goldfarb et al. Jul 2008 A1
20080188850 Mody et al. Aug 2008 A1
20080195126 Solem Aug 2008 A1
20080243249 Kohm et al. Oct 2008 A1
20080294175 Bardsley et al. Nov 2008 A1
20080312496 Zwolinski Dec 2008 A1
20090012538 Saliman et al. Jan 2009 A1
20090036768 Seehusen et al. Feb 2009 A1
20090156995 Martin et al. Jun 2009 A1
20090163934 Raschdorf, Jr. et al. Jun 2009 A1
20090177266 Powell et al. Jul 2009 A1
20090192510 Bahney Jul 2009 A1
20090198322 Deem et al. Aug 2009 A1
20090204005 Keast et al. Aug 2009 A1
20090209955 Forster et al. Aug 2009 A1
20090209991 Hinchliffe et al. Aug 2009 A1
20090270858 Hauck et al. Oct 2009 A1
20090276039 Meretei Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090326567 Goldfarb et al. Dec 2009 A1
20100016958 St. Goer et al. Jan 2010 A1
20100022823 Goldfarb et al. Jan 2010 A1
20100044410 Argentine et al. Feb 2010 A1
20100121437 Subramanian et al. May 2010 A1
20100152612 Headley et al. Jun 2010 A1
20100217261 Watson Aug 2010 A1
20100262231 Tuval et al. Oct 2010 A1
20100268226 Epp et al. Oct 2010 A1
20100298929 Thornton et al. Nov 2010 A1
20110009864 Bucciaglia et al. Jan 2011 A1
20110184405 Mueller Jul 2011 A1
20110224710 Bleich Sep 2011 A1
20110238052 Robinson Sep 2011 A1
20120022527 Woodruff Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120065464 Ellis et al. Mar 2012 A1
20120150194 Odermatt et al. Jun 2012 A1
20120157765 Mitelberg Jun 2012 A1
20120172915 Fifer et al. Jul 2012 A1
20120179184 Orlov Jul 2012 A1
20120265222 Gordin et al. Oct 2012 A1
20120310330 Buchbinder et al. Dec 2012 A1
20120316639 Kleinschrodt Dec 2012 A1
20120330348 Strauss et al. Dec 2012 A1
20130041314 Dillon Feb 2013 A1
20130066341 Ketai et al. Mar 2013 A1
20130066342 Dell et al. Mar 2013 A1
20130109910 Alexander et al. May 2013 A1
20130172828 Kappel et al. Jul 2013 A1
20130317515 Kuroda et al. Nov 2013 A1
20140039511 Morris et al. Feb 2014 A1
20140135799 Henderson May 2014 A1
20140228871 Cohen et al. Aug 2014 A1
20140276913 Tah et al. Sep 2014 A1
20140309670 Bakos et al. Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140350662 Vaturi Nov 2014 A1
20140358224 Tegels et al. Dec 2014 A1
20140364866 Dryden et al. Dec 2014 A1
20140379074 Spence et al. Dec 2014 A1
20150005704 Heisel et al. Jan 2015 A1
20150005801 Marquis et al. Jan 2015 A1
20150051698 Ruyra Baliarda et al. Feb 2015 A1
20150094800 Chawla Apr 2015 A1
20150112430 Creaven et al. Apr 2015 A1
20150211946 Pons et al. Jul 2015 A1
20150230947 Krieger et al. Aug 2015 A1
20150257877 Hernandez Sep 2015 A1
20150306806 Dando et al. Oct 2015 A1
20150313581 Wolfe et al. Nov 2015 A1
20160015410 Asirvatham et al. Jan 2016 A1
20160074165 Spence et al. Mar 2016 A1
20160174979 Wei Jun 2016 A1
20160317174 Dake Nov 2016 A1
20170042678 Ganesan et al. Feb 2017 A1
20170100183 Iaizzo et al. Apr 2017 A1
20170202559 Taha Jul 2017 A1
20170232238 Biller et al. Aug 2017 A1
20180008268 Khairkhahan Jan 2018 A1
20180028215 Cohen Feb 2018 A1
20180092661 Prabhu Apr 2018 A1
20180133010 Kizuka May 2018 A1
20180161159 Lee Jun 2018 A1
20180360457 Ellis et al. Dec 2018 A1
20190029790 Bak-Boychuk et al. Jan 2019 A1
20190183571 De Marchena Jun 2019 A1
20190298517 Sanchez et al. Oct 2019 A1
20190307458 Mathis Oct 2019 A1
20210113232 Ortiz et al. Apr 2021 A1
20210145574 Childs et al. May 2021 A1
Foreign Referenced Citations (129)
Number Date Country
1469724 Jan 2004 CN
102770080 Nov 2012 CN
103841899 Jun 2014 CN
104244841 Dec 2014 CN
3504292 Jul 1986 DE
9100873 Apr 1991 DE
10116168 Nov 2001 DE
0179562 Jul 1989 EP
0558031 Feb 1993 EP
0684012 Nov 1995 EP
0727239 Aug 1996 EP
0782836 Jul 1997 EP
1674040 Jun 2006 EP
1980288 Oct 2008 EP
2005912 Dec 2008 EP
2537487 Dec 2012 EP
2641570 Sep 2013 EP
2702965 Mar 2014 EP
2740419 Jun 2014 EP
3009103 Apr 2016 EP
2705556 Dec 1994 FR
2768324 Mar 1999 FR
2903292 Jan 2008 FR
1598111 Sep 1981 GB
2151142 Jul 1985 GB
2001-517529 Oct 2001 JP
2006528911 Dec 2006 JP
2013516244 May 2013 JP
2014523274 Sep 2014 JP
2018-030008 Mar 2018 JP
WO 1981000668 Mar 1981 WO
WO 1991001689 Feb 1991 WO
WO 1994018881 Sep 1994 WO
WO 1994018893 Sep 1994 WO
WO 1995008292 Mar 1995 WO
WO 1995011620 May 1995 WO
WO 1995015715 Jun 1995 WO
WO 1996020655 Jul 1996 WO
WO 1996022735 Aug 1996 WO
WO 1996030072 Oct 1996 WO
WO 1997018746 May 1997 WO
WO 1997025927 Jul 1997 WO
WO 1997026034 Jul 1997 WO
WO 1997038748 Oct 1997 WO
WO 1997039688 Oct 1997 WO
WO 1997048436 Dec 1997 WO
WO 1998007375 Feb 1998 WO
WO 1998024372 Jun 1998 WO
WO 1998030153 Jul 1998 WO
WO 1998032382 Jul 1998 WO
WO 1998035638 Aug 1998 WO
WO 1999000059 Jan 1999 WO
WO 1999001377 Jan 1999 WO
WO 1999007295 Feb 1999 WO
WO 1999013777 Mar 1999 WO
WO 1999044524 Sep 1999 WO
WO 2000003651 Jan 2000 WO
WO 2000003759 Jan 2000 WO
WO 2000012168 Mar 2000 WO
WO 2000044313 Aug 2000 WO
WO 2000060995 Oct 2000 WO
WO 2001000114 Jan 2001 WO
WO 2001026557 Apr 2001 WO
WO 2001028432 Apr 2001 WO
WO 2001028455 Apr 2001 WO
WO 2001047438 Jul 2001 WO
WO 2001049213 Jul 2001 WO
WO 2001050985 Jul 2001 WO
WO 2001054618 Aug 2001 WO
WO 2001066001 Sep 2001 WO
WO 2001070320 Sep 2001 WO
WO 2001089440 Nov 2001 WO
WO 2002000099 Jan 2002 WO
WO 2002001999 Jan 2002 WO
WO 2002003892 Jan 2002 WO
WO 2002034167 May 2002 WO
WO 2002060352 Aug 2002 WO
WO 2002062263 Aug 2002 WO
WO 2003001893 Jan 2003 WO
WO 2003003930 Jan 2003 WO
WO 2003020179 Mar 2003 WO
WO 2003028558 Apr 2003 WO
WO 2003037171 May 2003 WO
WO 2003047467 Jun 2003 WO
WO 2003049619 Jun 2003 WO
WO 2003073913 Sep 2003 WO
WO 2003105667 Dec 2003 WO
WO 2004006810 Jan 2004 WO
WO 2004012583 Feb 2004 WO
WO 2004012789 Feb 2004 WO
WO 2004014282 Feb 2004 WO
WO 2004019811 Mar 2004 WO
WO 2004030570 Apr 2004 WO
WO 2004037317 May 2004 WO
WO 2004045370 Jun 2004 WO
WO 2004045378 Jun 2004 WO
WO 2004045463 Jun 2004 WO
WO 2004062725 Jul 2004 WO
WO 2004082523 Sep 2004 WO
WO 2004082538 Sep 2004 WO
WO 2004103162 Dec 2004 WO
WO 2004112585 Dec 2004 WO
WO 2005018507 Mar 2005 WO
WO 2005032421 Apr 2005 WO
WO 2005062931 Jul 2005 WO
WO 2005112792 Dec 2005 WO
WO 2006037073 Apr 2006 WO
WO 2006105008 Oct 2006 WO
WO 2006105009 Oct 2006 WO
WO 2006113906 Oct 2006 WO
WO 2006115876 Nov 2006 WO
WO 2007136829 Nov 2007 WO
WO 2008103722 Aug 2008 WO
WO 2010024801 Mar 2010 WO
WO 2010121076 Oct 2010 WO
WO 2012020521 Feb 2012 WO
WO 2013049734 Apr 2013 WO
WO 2013103934 Jul 2013 WO
WO 2014064694 May 2014 WO
WO 2014121280 Aug 2014 WO
WO 2016022797 Feb 2016 WO
WO 2016144708 Sep 2016 WO
WO 2016150806 Sep 2016 WO
WO 2017223073 Dec 2017 WO
WO 2018009718 Jan 2018 WO
WO 2018106482 Jun 2018 WO
2018236766 Dec 2018 WO
2019040943 Feb 2019 WO
2019195336 Oct 2019 WO
Non-Patent Literature Citations (81)
Entry
Supplementary European Search Report issued in European Application No. 05753261.6 dated Jun. 9, 2011, 3 pages total.
Nishimura, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. Jun. 10, 2014; 63(22):2438-88.
Abe et al, “De Vega's Annuloplasty for Acquired Tricuspid Disease: Early and Late Results in 110 Patients”, Ann. Thorac. Surg., pp. 670-676, vol. 48 (Jan. 1989).
Abe et al., “Updated in 1996—De Vega's Annuloplasty for Acquired Tricuspid Disease: Early and Late Results in 110 Patients”, Ann. Thorac. Surg., pp. 1876-1877, vol. 62 (1996).
Alfieri et al., “An Effective Technique to Correct Anterior Mitral Leaflet Prolapse,” J. Card Surg., 14:468-470 (1999).
Alfieri et al., “Novel Suture Device for Beating Heart Mitral Leaflet Approximation,” Annals of Thoracic Surgery, 74:1488-1493 (2002).
Alfieri et al., “The edge to edge technique,” The European Association for Cardio-Thoracic Surgery 14th Annual Meeting, Oct. 7-11, 2000, Book of Proceedings.
Ali Khan et al, Blade Atrial Septostomy: Experience with the First 50 Procedures, Cathet. Cardiovasc. Diagn., Aug. 1991, pp. 257-262, vol. 23.
Alvarez et al, Repairing the Degenerative Mitral Valve: Ten to Fifteen-year Follow-up, Journal of Thoracic Cardiovascular Surgery, Aug. 1996, pp. 238-247, vol. 112, No. 2.
Bailey, “Mitral Regurgitation” in Surgery of the Heart, Chapter 20, pp. 686-737 (1955).
Borghetti et al., “Preliminary observations on haemodynamics during physiological stress conditions following ‘double-orifice’ mitral valve repair,” European Journal of Cardio-thoracic Surgery, 20:262-269 (2001).
Castedo, “Edge-to-Edge Tricuspid Repair for Redeveloped Valve Incompetence after DeVega's Annuloplasty,” Ann Thora Surg., 75:605-606 (2003).
Chinese Office Action issued in Chinese Application No. 200980158707.2 dated Sep. 9, 2013.
Communication dated Apr. 16, 2018 from the European Patent Office in counterpart European application No. 04752603.3.
Communication dated Apr. 28, 2017 issued by the European Patent Office in counterpart application No. 16196023.2.
Communication dated Jan. 26, 2017, from the European Patent Office in counterpart European application No. 16196023.2.
Dang N C et al., “Surgical Revision After Percutaneous Mitral Valve Repair with a Clip: Initial Multicenter Experience”,The Annals of Thracic Surgery,Elsevier, United States, vol. 80, No. 6, pp. 2338-2342, (Dec. 1, 2005), XP027732951, ISSN:0003-4975 [retrieved on Dec. 1, 2005].
Dottori et al., “Echocardiographic imaging of the Alfieri type mitral valve repair,” Ital. Heart J., 2(4):319-320 (2001).
Downing et al., “Beating heart mitral valve surgery: Preliminary model and methodology,” Journal of Thoracic and Cardiovascular Surgery, 123(6):1141-1146 (2002).
Extended European Search Report, dated Oct. 17, 2014, issued in European Patent Application No. 06751584.1.
Falk et al., “Computer-Enhanced Mitral Valve Surgery: Toward a Total Endoscopic Procedure,” Seminars in Thoracic and Cardiovascular Surgery, 11(3):244-249 (1999).
Feldman et al, Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of Everest II. J Am Coll Cardiol. Dec. 29, 2015; 66(25):2844-2854.
Fucci et al, Improved Results with Mitral Valve Repair Using New Surgical Techniques, Eur. J. Cardiothorac. Surg., Nov. 1995, pp. 621-627, vol. 9.
Garcia-Rinaldi et al., “Left Ventricular Volume Reduction and Reconstruction is Ischemic Cardiomyopathy,” Journal of Cardiac Surgery, 14:199-210 (1999).
Izzat et al., “Early Experience with Partial Left Ventriculectomy in the Asia-Pacific Region,” Annuals of Thoracic Surgery, 67:1703-1707 (1999).
Kallner et al., “Transaortic Approach for the Alfieri Stitch,” Ann Thorac Surg, 71:378-380 (2001).
Kavarana et al., “Transaortic Repair of Mitral Regurgitation,” The Heart Surgery Forum, #2000-2389, 3(1):24-28 (2000).
Khan et al., “Blade Atrial Septostomy; Experience with the First 50 Procedures”, Catheterization and Cardiovascular Diagnosis, 23:257-262 (1991).
Kron et al., “Surgical Relocation of the Posterior Papillary Muscle in Chronic Ischemic Mitral Regurgitation,” Annals. of Thoracic Surgery, 74:600-601 (2002).
Kruger et al., “P73—Edge to Edge Technique in Complex Mitral Valve Repair,” Thorac Cardiovasc Surg., 48(Suppl. 1):106 (2000).
Maisano et al., “Valve Repair for Traumatic Tricuspid Regurgitation,” Eur. J. Cardio-Thorac Surg, 10:867-873 (1996).
Maisano et al., “The Edge-to-edge Technique: A Simplified Method to Correct Mitral Insufficiency”, Eur. J. Cardiothorac. Surg., pp. 240-246, vol. 13 ( Jan. 14, 1998).
Maisano et al., “The Double Orifice Repair for Barlow Disease: a Simple Solution for a Complex Repair,” Supplement | Circulation, 100(18):1-94 (Nov. 1999).
Maisano et al., “The Double Orifice Technique as a Standardized Approach to Treat Mitral Regurgitation due to Severe Myxomatous Disease: Surgical Technique,” European Journal of Cardio-thoracic Surgery, 17:201-205 (2000).
Maisano et al., “The Future of Transcatheter Mitral Valve Interventions: Competitive or Complementary Role of Repair vs. Replacement?”, Eur Heart J.36(26):1651-1659 ( Jul. 7, 2015 ).
Mantovani et al., “Edge-to-edge Repair of Congenital Familiar Tricuspid Regurgitation: Case Report,” J. Heart Valve Dis., 9:641-643 (2000).
McCarthy et al, “Tricuspid Valve Repair With the Cosgrove-Edwards Annuloplasty System”, Ann. Thorac. Surg., 64:267-8 ( Jan. 16, 1997).
McCarthy et al., “Partial Left Ventriculectomy and Mitral Valve Repair for End-Stage Congestive Heart Failure,” European Journal of Cardio-thoracic Surgery, 13:337-343 (1998).
Moainie et al., “Correction of Traumatic Tricuspid Regurgitation Using the Double Orifice Technique,” Annals of Thoracic Surgery, 73:963-965 (2002).
Morales et al., “Development of an Off Bypass Mitral Valve Repair,” The Heart Surgery Forum #1999-4693, 2(2):115-120 (1999).
Nakanishi et al., “Early Outcome with the Alfieri Mitral Valve Repair,” J. Cardiol., 37: 263-266 (2001) [Abstract in English; Article in Japanese].
Nielsen et al., “Edge-to-Edge Mitral Repair: Tension of the Approximating Suture and Leaflet Deformation During Acute Ischemic Mitral Regurgitation in the Ovine Heart,” Circulation, 104(Suppl. I):I-29-I-35 (2001).
Nishimura et al, 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. Jun. 10, 2014; 63(22):2438-2488.
Park et al., Clinical Use of Blade Atrial Septostomy, Circulation, pp. 600-608, vol. 58, No. 4 (1978 ).
Privitera et al., “Alfieri Mitral Valve Repair: Clinical Outcome and Pathology,” Circulation, 106:e173-e174 (2002).
Redaelli et al., “A Computational Study of the Hemodynamics After ‘Edge-To-Edge’ Mitral Valve Repair,” Journal of Biomechanical Engineering, 123:565-570 (2001).
Reul et al., “Mitral Valve Reconstruction for Mitral Insufficiency,” Progress in Cardiovascular Diseases, XXXIX(6):567-599 (1997).
Rose et al., “Late MitraClip Failure: Removal Technique for Leaflet-Sparing Mitral Valve Repair”, Journal of Cardiac Surgery, (Jul. 4, 2012), XP055047339, DOI: 10.1111/j. 1540-8191.2012.01483.x [retrieved on Dec. 11, 2012].
Takizawa H et al: “Development of a microfine active bending catheter equipped with MIF tactile sensors”, Micro Electro Mechanical Systems, 1999. MEMS '99. Twelfth IEEE Interna Tional Conference On Orlando, FL, USA Jan. 17-21, 1999, Piscataway, NJ, USA, IEEE, US, Jan. 17, 1999 (Jan. 17, 1999), pp. 412-417, XP010321677, ISBN: 978-0-7803-5194-3 figures 1-3.
Tamura et al., “Edge to Edge Repair for Mitral Regurgitation in a Patient with Chronic Hemodialysis: Report of a Case,” Kyobu Geka. The Japanese Journal of Thoracic Surgery, 54(9):788-790 (2001).
Timek et al., “Edge-to-edge mitral repair: gradients and three-dimensional annular dynamics in vivo during inotropic stimulation,” Eur J. of Cardiothoracic Surg., 19:431-437 (2001).
Totaro, “Mitral valve repair for isolated prolapse of the anterior leaflet: an 11-year follow-up,” European Journal of Cardio-thoracic Surgery, 15:119-126 (1999).
Uchida et al., Percutaneous Cardiomyotomy and Valvulotomy with Angioscopic Guidance, Am. Heart J., pp. 1221-1224, vol. 121 (Apr. 1991).
Umana et al., ‘Bow-Tie’ Mitral Valve Repair: An Adjuvant Technique for Ischemic Mitral Regurgitation, Ann. Thorac. Surg., pp. 1640-1646, vol. 66 (May 12, 1998).
Votta et al., “3-D Computational Analysis of the Stress Distribution on the Leaflets after Edge-to-Edge Repair of Mitral Regurgitation,” Journal of Heart Valve Disease, 11:810-822 (2002).
U.S. Appl. No. 14/216,787, Apr. 8, 2016, Office Action.
U.S. Appl. No. 14/216,787, Nov. 7, 2016, Notice of Allowance.
U.S. Appl. No. 14/216,813, Mar. 9, 2017, Office Action.
U.S. Appl. No. 14/216,813, Dec. 15, 2017, Office Action.
U.S. Appl. No. 14/216,813, Apr. 6, 2018, Office Action.
U.S. Appl. No. 14/577,852, Oct. 20, 2016, Office Action.
U.S. Appl. No. 14/577,852, May 16, 2017, Office Action.
U.S. Appl. No. 14/577,852, Sep. 7, 2017, Office Action.
U.S. Appl. No. 14/577,852, Apr. 25, 2018, Notice of Allowance.
U.S. Appl. No. 15/423,060, Apr. 25, 2019, Office Action.
U.S. Appl. No. 15/423,060, Aug. 19, 2019, Office Action.
U.S. Appl. No. 15/423,060, Oct. 28, 2019, Office Action.
U.S. Appl. No. 15/423,060, Jan. 27, 2020, Notice of Allowance.
U.S. Appl. No. 15/642,245, Aug. 9, 2019, Office Action.
U.S. Appl. No. 15/642,245, Nov. 6, 2019, Notice of Allowance.
U.S. Appl. No. 15/642,245, Jan. 29, 2019, Notice of Allowance.
U.S. Appl. No. 15/642,245, Mar. 27, 2020, Notice of Allowance.
U.S. Appl. No. 15/724,545, Dec. 27, 2019, Office Action.
U.S. Appl. No. 15/724,545, May 1, 2020, Office Action.
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic and Cardiovascular Surgery, 122:674-681 (2001).
Bhudia et al., “Edge-to-Edge (Alfieri) Mitral Repair: Results in Diverse Clinical Settings,” Ann Thorac Surg, 77:1598-1606 (2004).
Maisano et al., The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? Eur Heart J. Jul. 7, 2015; 36(26):1651-1659.
Tager et al., Long-Term Follow-Up of Rheumatic Patients Undergoing Left-Sided Valve Replacement With Tricuspid Annuloplasty—Validity of Preoperative Echocardiographic Criteria in the Decision to Perform Tricuspid Annuloplasty, Am. J. Cardiol., Apr. 15, 1998, pp. 1013-1016, vol. 81.
U.S. Provisional Application filed Jul. 6, 2016, by Khairkhahan., U.S. Appl. No. 62/359,121.
U.S. Provisional Application filed Nov. 7, 2016, by Khairkhahan., U.S. Appl. No. 62/418,571.
U.S. Provisional Application filed Oct. 22, 2018, by Dale et al., U.S. Appl. No. 62/748,947.
Related Publications (1)
Number Date Country
20200121460 A1 Apr 2020 US
Provisional Applications (1)
Number Date Country
62748947 Oct 2018 US